Hospital Supply Status (HSS) and Principal Supply Status (PSS) - Cumulative to November 2024
The expiry date of the supply period is 30 June of the year indicated unless otherwise stated. Please note that the supply may have been awarded for a wider scope than just those presentation(s) listed below.
| Status | Chemical | Presentation | Brand | Pharmacode | SSS/PSS Period |
|---|---|---|---|---|---|
| PSS | Abacavir sulphate with lamivudine | Tab 600 mg with lamivudine 300 mg | Abacavir/lamivudine Viatris | 2632365 | May 2023 to 2025 |
| PSS | Acarbose | Tab 100 mg | Accarb | 2402416 | Feb 2025 to 2027 |
| PSS | Acarbose | Tab 50 mg | Accarb | 2402408 | Feb 2025 to 2027 |
| PSS | Acetylcysteine | Inj 200 mg per ml, 10 ml ampoule | DBL Acetylcysteine | 2260794 | Apr 2025 to 2027 |
| PSS | Aciclovir | Eye oint 3% | ViruPOS | 2490803 | Feb 2025 to 2027 |
| PSS | Aciclovir | Inj 250 mg vial | Aciclovir-Baxter | 2599414 | Feb 2025 to 2027 |
| PSS | Aciclovir | Tab dispersible 200 mg | Lovir | 471704 | Mar 2023 to 2025 |
| PSS | Aciclovir | Tab dispersible 400 mg | Lovir | 471690 | Apr 2023 to 2025 |
| PSS | Aciclovir | Tab dispersible 800 mg | Lovir | 471712 | Apr 2023 to 2025 |
| PSS | Acitretin | Cap 10 mg | Novatretin | 2384167 | Jul 2024 to 2026 |
| PSS | Acitretin | Cap 25 mg | Novatretin | 2384175 | Jul 2024 to 2026 |
| PSS | Adalimumab (Amgevita) | Inj 20 mg per 0.4 ml prefilled syringe | Amgevita | 2631121 | Oct 2022 to 31~Jul~2026 |
| PSS | Adalimumab (Amgevita) | Inj 40 mg per 0.8 ml prefilled pen | Amgevita | 2631105 | Oct 2022 to 31~Jul~2026 |
| PSS | Adalimumab (Amgevita) | Inj 40 mg per 0.8 ml prefilled syringe | Amgevita | 2631113 | Oct 2022 to 31~Jul~2026 |
| PSS | Adenosine | Inj 3 mg per ml, 10 ml vial | Adenosine Baxter | 2655780 | Dec 2024 to 2027 |
| PSS | Adenosine | Inj 3 mg per ml, 2 ml vial | Adsine | 2655799 | Dec 2024 to 2027 |
| PSS | Adrenaline | Inj 0.15 mg per 0.3 ml auto-injector | Epipen Jr | 208191 | Jul 2023 to 2025 |
| PSS | Adrenaline | Inj 0.3 mg per 0.3 ml auto-injector | Epipen | 223972 | Jul 2023 to 2025 |
| PSS | Alendronate sodium | Tab 70 mg | Fosamax | 2022133 | Jul 2024 to 2026 |
| PSS | Alendronate sodium with colecalciferol | Tab 70 mg with colecalciferol 5,600 iu | Fosamax Plus | 2337053 | Jul 2024 to 2026 |
| PSS | Alfentanil | Inj 0.5 mg per ml, 2 ml ampoule | Medsurge | 2650991 | Feb 2024 to 2026 |
| PSS | Allopurinol | Tab 100 mg | Ipca-Allopurinol | 2666855 | Jun 2024 to 2026 |
| PSS | Allopurinol | Tab 300 mg | Ipca-Allopurinol | 2666863 | Jun 2024 to 2026 |
| PSS | Ambrisentan | Tab 10 mg | Ambrisentan Viatris | 2626454 | Dec 2023 to 2026 |
| PSS | Ambrisentan | Tab 5 mg | Ambrisentan Viatris | 2626446 | Dec 2023 to 2026 |
| PSS | Amikacin | Inj 250 mg per ml, 2 ml vial | DBL Amikacin | 2572214 | Dec 2024 to 2027 |
| PSS | Amiodarone hydrochloride | Inj 50 mg per ml, 3 ml ampoule | Max Health | 2565129 | Dec 2022 to 2025 |
| PSS | Amiodarone hydrochloride | Tab 100 mg | Aratac | 770620 | Dec 2022 to 2025 |
| PSS | Amiodarone hydrochloride | Tab 200 mg | Aratac | 770639 | Dec 2022 to 2025 |
| PSS | Amisulpride | Tab 100 mg | Sulprix | 2609401 | Dec 2024 to 2027 |
| PSS | Amisulpride | Tab 200 mg | Sulprix | 2609398 | Dec 2024 to 2027 |
| PSS | Amisulpride | Tab 400 mg | Sulprix | 2609428 | Dec 2024 to 2027 |
| PSS | Amitriptyline | Tab 10 mg | Arrow-Amitriptyline | 2404451 | Mar 2024 to 2026 |
| PSS | Amitriptyline | Tab 25 mg | Arrow-Amitriptyline | 2461250 | Mar 2024 to 2026 |
| PSS | Amitriptyline | Tab 50 mg | Arrow-Amitriptyline | 2461269 | Mar 2024 to 2026 |
| PSS | Amlodipine | Tab 10 mg | Vasorex | 2592525 | Feb 2024 to 2026 |
| PSS | Amlodipine | Tab 2.5 mg | Vasorex | 2592509 | Feb 2024 to 2026 |
| PSS | Amlodipine | Tab 5 mg | Vasorex | 2592517 | Feb 2024 to 2026 |
| PSS | Amorolfine | Nail soln 5% | MycoNail | 2461633 | Feb 2024 to 2026 |
| PSS | Amoxicillin | Cap 250 mg | Miro-Amoxicillin | 2669617 | Sep 2024 to 2025 |
| PSS | Amoxicillin | Cap 500 mg | Miro-Amoxicillin | 2669625 | Aug 2024 to 2025 |
| PSS | Amoxicillin | Grans for oral liq 125 mg per 5 ml | Alphamox 125 | 2503557 | Feb 2024 to 2026 |
| PSS | Amoxicillin | Grans for oral liq 250 mg per 5 ml | Alphamox 250 | 2503565 | Feb 2024 to 2026 |
| PSS | Amoxicillin with clavulanic acid | Grans for oral liq 50 mg with clavulanic acid 12.5 mg per ml | Amoxiclav Devatis Forte | 2684748 | Jun 2025 to 2027 |
| PSS | Amoxicillin with clavulanic acid | Tab 500 mg with clavulanic acid 125 mg | Curam Duo 500/125 | 2602121 | Feb 2024 to 2026 |
| PSS | Anastrozole | Tab 1 mg | Anatrole | 2520079 | Dec 2023 to 2026 |
| PSS | Aprepitant | Cap 2 x 80 mg and 1 x 125 mg | Emend Tri-Pack | 2244098 | Jan 2025 to 2027 |
| PSS | Aqueous cream | Crm 100 g | Evara | 2682303 | Mar 2025 to 2027 |
| PSS | Aqueous cream | Crm 500 g | Evara | 2555115 | Mar 2025 to 2027 |
| PSS | Aripiprazole | Tab 10 mg | Aripiprazole Sandoz | 2544539 | Oct 2022 to 2025 |
| PSS | Aripiprazole | Tab 15 mg | Aripiprazole Sandoz | 2544547 | Oct 2022 to 2025 |
| PSS | Aripiprazole | Tab 20 mg | Aripiprazole Sandoz | 2544555 | Oct 2022 to 2025 |
| PSS | Aripiprazole | Tab 30 mg | Aripiprazole Sandoz | 2544563 | Oct 2022 to 2025 |
| PSS | Aripiprazole | Tab 5 mg | Aripiprazole Sandoz | 2544520 | Oct 2022 to 2025 |
| PSS | Ascorbic acid | Tab 100 mg | Cvite | 2642255 | Feb 2023 to 2025 |
| PSS | Aspirin | Tab dispersible 300 mg | Ethics Aspirin | 2184338 | May 2024 to 2026 |
| PSS | Aspirin | Tab 100 mg | Ethics Aspirin EC | 2184281 | Jun 2024 to 2026 |
| PSS | Aspirin | Tab 100 mg | Ethics Aspirin EC | 2213621 | Jun 2024 to 2026 |
| HSS | Atazanavir sulphate | Cap 150 mg | Atazanavir Mylan | 2640015 | May 2023 to 2025 |
| PSS | Atazanavir sulphate | Cap 200 mg | Atazanavir Viatris | 2660024 | Jun 2024 to 2025 |
| PSS | Atenolol | Tab 100 mg | Atenolol Viatris | 2627159 | Feb 2025 to 2027 |
| PSS | Atenolol | Tab 50 mg | Viatris | 2627140 | Feb 2025 to 2027 |
| PSS | Atomoxetine | Cap 10 mg | APO-Atomoxetine | 2638517 | Aug 2024 to 2026 |
| PSS | Atomoxetine | Cap 100 mg | APO-Atomoxetine | 2638541 | Aug 2024 to 2026 |
| PSS | Atomoxetine | Cap 18 mg | APO-Atomoxetine | 2637065 | Aug 2024 to 2026 |
| PSS | Atomoxetine | Cap 25 mg | APO-Atomoxetine | 2637073 | Aug 2024 to 2026 |
| PSS | Atomoxetine | Cap 40 mg | APO-Atomoxetine | 2637081 | Aug 2024 to 2026 |
| PSS | Atomoxetine | Cap 60 mg | APO-Atomoxetine | 2638525 | Aug 2024 to 2026 |
| PSS | Atomoxetine | Cap 80 mg | APO-Atomoxetine | 2638533 | Aug 2024 to 2026 |
| PSS | Atorvastatin | Tab 10 mg | Lorstat | 2493586 | Dec 2024 to 2027 |
| PSS | Atorvastatin | Tab 20 mg | Lorstat | 2493594 | Dec 2024 to 2027 |
| PSS | Atorvastatin | Tab 40 mg | Lorstat | 2493608 | Dec 2024 to 2027 |
| PSS | Atorvastatin | Tab 80 mg | Lorstat | 2493616 | Dec 2024 to 2027 |
| PSS | Atropine sulphate | Inj 600 mcg per ml, 1 ml ampoule | Martindale | 2528754 | Feb 2025 to 2027 |
| PSS | Atropine sulphate | Eye drops 1% | Atropt | 200905 | Feb 2024 to 2026 |
| PSS | Azacitidine | Inj 100 mg vial | Azacitidine Dr Reddy's | 2550083 | Mar 2025 to 2027 |
| PSS | Azathioprine | Tab 25 mg | Azamun | 2465345 | Apr 2023 to 2025 |
| PSS | Azathioprine | Tab 50 mg | Azamun | 390003 | Mar 2023 to 2025 |
| PSS | Bacillus calmette-guerin vaccine | Inj Mycobacterium bovis BCG (Bacillus Calmette-Guerin), Danish strain 1331, live attenuated, vial with diluent | BCG Vaccine AJV | 2461854 | Dec 2024 to 2027 |
| PSS | Baclofen | Inj 2 mg per ml, 5 ml ampoule | Sintetica Baclofen Intrathecal | 2688417 | Mar 2025 to 2027 |
| PSS | Baclofen | Tab 10 mg | Pacifen | 403903 | Dec 2024 to 2027 |
| PSS | Bendamustine hydrochloride | Inj 100 mg vial | Bendamustine Sandoz | 2691442 | Apr 2025 to 2027 |
| PSS | Bendamustine hydrochloride | Inj 25 mg vial | Bendamustine Sandoz | 2691434 | Apr 2025 to 2027 |
| PSS | Bendroflumethiazide [Bendrofluazide] | Tab 2.5 mg | Arrow-Bendrofluazide | 2351420 | Mar 2024 to 2026 |
| PSS | Bendroflumethiazide [Bendrofluazide] | Tab 5 mg | Arrow-Bendrofluazide | 2351439 | Mar 2024 to 2026 |
| PSS | Benzylpenicillin sodium [Penicillin G] | Inj 600 mg (1 million units) vial | Sandoz | 433748 | Feb 2024 to 2026 |
| PSS | Betahistine dihydrochloride | Tab 16 mg | Serc | 2611376 | Dec 2023 to 2026 |
| PSS | Betamethasone dipropionate | Crm 0.05% | Diprosone | 210870 | Jul 2024 to 2026 |
| PSS | Betamethasone dipropionate | Oint 0.05% | Diprosone | 210897 | Jul 2024 to 2026 |
| PSS | Betamethasone dipropionate with calcipotriol | Oint 500 mcg with calcipotriol 50 mcg per g | Daivobet | 2170914 | Dec 2024 to 2027 |
| PSS | Betamethasone dipropionate with calcipotriol | Gel 500 mcg with calcipotriol 50 mcg per g | Daivobet | 2553015 | Dec 2024 to 2027 |
| PSS | Betamethasone valerate | Crm 0.1% | Beta Cream | 2188740 | Feb 2025 to 2027 |
| PSS | Betamethasone valerate | Oint 0.1% | Beta Ointment | 2188759 | Feb 2025 to 2027 |
| PSS | Betamethasone valerate | Scalp app 0.1% | Beta Scalp | 512877 | Feb 2025 to 2027 |
| PSS | Bezafibrate | Tab 200 mg | Bezalip | 474223 | Mar 2025 to 2027 |
| PSS | Bezafibrate | Tab long-acting 400 mg | Bezalip Retard | 354333 | Mar 2025 to 2027 |
| PSS | Bicalutamide | Tab 50 mg | Binarex | 2523655 | Dec 2023 to 2026 |
| PSS | Bimatoprost | Eye drops 0.03% | Lumigan | 2109220 | Jan 2025 to 2027 |
| PSS | Bisacodyl | Suppos 10 mg | Lax-Suppositories | 2485397 | Feb 2025 to 2027 |
| PSS | Bisacodyl | Tab 5 mg | Bisacodyl Viatris | 2631881 | Jan 2023 to 2025 |
| PSS | Bisoprolol fumarate | Tab 10 mg | Ipca-Bisoprolol | 2660377 | Apr 2024 to 2026 |
| PSS | Bisoprolol fumarate | Tab 2.5 mg | Ipca-Bisoprolol | 2660350 | Apr 2024 to 2026 |
| PSS | Bisoprolol fumarate | Tab 5 mg | Ipca-Bisoprolol | 2660369 | Apr 2024 to 2026 |
| PSS | Bortezomib | Inj 3.5 mg vial | DBL Bortezomib | 2647583 | May 2023 to 2025 |
| PSS | Bosentan | Tab 125 mg | Bosentan Dr Reddy's | 2550075 | Jan 2025 to 2027 |
| PSS | Bosentan | Tab 62.5 mg | Bosentan Dr Reddy's | 2550067 | Jan 2025 to 2027 |
| PSS | Brimonidine tartrate | Eye drops 0.2% | Arrow-Brimonidine | 2396513 | Mar 2025 to 2027 |
| PSS | Brimonidine tartrate with timolol maleate | Eye drops 0.2% with timolol 0.5% | Combigan | 2203502 | Dec 2024 to 2027 |
| PSS | Brinzolamide | Eye drops 1% | Azopt | 2117061 | Dec 2024 to 2027 |
| PSS | Budesonide | Cap modified-release 3 mg | Budesonide Te Arai | 2661454 | Apr 2024 to 2025 |
| PSS | Budesonide | Nasal spray 100 mcg per dose | SteroClear | 2541068 | Feb 2025 to 2027 |
| PSS | Budesonide | Nasal spray 50 mcg per dose | SteroClear | 2541149 | Feb 2025 to 2027 |
| PSS | Bupivacaine hydrochloride | Inj 5 mg per ml, 4 ml ampoule | Marcain Isobaric | 2209284 | Feb 2024 to 2026 |
| PSS | Bupivacaine hydrochloride | Inj 2.5 mg per ml, 20 ml ampoule sterile pack | Marcain | 728071 | Feb 2024 to 2026 |
| PSS | Bupivacaine hydrochloride with fentanyl | Inj 1.25 mg with fentanyl 2 mcg per ml, 100 ml bag | Bupafen | 2594242 | Jan 2023 to 2025 |
| PSS | Bupivacaine hydrochloride with fentanyl | Inj 1.25 mg with fentanyl 2 mcg per ml, 200 ml bag | Bupafen | 2594250 | Jan 2023 to 2025 |
| PSS | Bupivacaine hydrochloride with glucose | Inj 0.5% with glucose 8%, 4 ml ampoule | Marcain Heavy | 2184435 | Sep 2022 to 2025 |
| PSS | Buprenorphine with naloxone | Tab 2 mg with naloxone 0.5 mg | Buprenorphine Naloxone BNM | 2574004 | Dec 2022 to 2025 |
| PSS | Buprenorphine with naloxone | Tab 8 mg with naloxone 2 mg | Buprenorphine Naloxone BNM | 2574012 | Dec 2022 to 2025 |
| PSS | Bupropion hydrochloride | Tab modified-release 150 mg | Zyban | 2439743 | May 2024 to 2026 |
| PSS | Buspirone hydrochloride | Tab 10 mg | Buspirone Viatris | 2615363 | Dec 2024 to 2027 |
| PSS | Buspirone hydrochloride | Tab 5 mg | Buspirone Viatris | 2615355 | Dec 2024 to 2027 |
| PSS | Calamine | Crm, aqueous, BP | healthE Calamine Aqueous | 2318628 | Apr 2025 to 2027 |
| PSS | Calcitriol | Cap 0.25 mcg | Calcitriol-AFT | 2091038 | Dec 2022 to 2025 |
| PSS | Calcitriol | Cap 0.5 mcg | Calcitriol-AFT | 2091011 | Dec 2022 to 2025 |
| PSS | Calcitriol | Cap 0.5 mcg | Calcitriol-AFT | 2691663 | Dec 2022 to 2025 |
| PSS | Calcium carbonate | Tab 1.25 g (500 mg elemental) | Calci-Tab 500 | 2212269 | Feb 2024 to 2026 |
| PSS | Candesartan cilexetil | Tab 16 mg | Candestar | 2380420 | Feb 2025 to 2027 |
| PSS | Candesartan cilexetil | Tab 32 mg | Candestar | 2380439 | Feb 2025 to 2027 |
| PSS | Candesartan cilexetil | Tab 4 mg | Candestar | 2380404 | Feb 2025 to 2027 |
| PSS | Candesartan cilexetil | Tab 8 mg | Candestar | 2380412 | Feb 2025 to 2027 |
| PSS | Capecitabine | Tab 150 mg | Capecitabine Viatris | 2634929 | Jan 2024 to 2025 |
| PSS | Capecitabine | Tab 500 mg | Capecitabine Viatris | 2634937 | Jan 2024 to 2025 |
| PSS | Captopril | Oral liq 5 mg per ml | DP-Captopril | 2657775 | Apr 2024 to 2026 |
| PSS | Carbimazole | Tab 5 mg | Neo-Mercazole | 594423 | Sep 2022 to 2025 |
| PSS | Carboplatin | Inj 10 mg per ml, 45 ml vial | Carboplatin Accord | 2678926 | Dec 2024 to 2027 |
| PSS | Carmustine | Inj 100 mg vial | BiCNU | 2571234 | Sep 2022 to 2025 |
| PSS | Caspofungin | Inj 50 mg vial | Alchemy Caspofungin | 2647567 | Apr 2023 to 2025 |
| PSS | Caspofungin | Inj 70 mg vial | Alchemy Caspofungin | 2647575 | Apr 2023 to 2025 |
| PSS | Cefaclor | Cap 250 mg | Ranbaxy-Cefaclor | 2149389 | Apr 2023 to 2025 |
| PSS | Cefaclor | Grans for oral liq 25 mg per ml | Ranbaxy-Cefaclor | 471674 | Apr 2023 to 2025 |
| PSS | Cefalexin | Cap 250 mg | Cephalexin ABM | 2498871 | Apr 2023 to 2025 |
| PSS | Cefalexin | Cap 500 mg | Cephalexin ABM | 2361248 | Apr 2023 to 2025 |
| PSS | Cefalexin | Grans for oral liq 25 mg per ml | Flynn | 2640481 | Jan 2023 to 2025 |
| PSS | Cefalexin | Grans for oral liq 50 mg per ml | Flynn | 2640503 | Jan 2023 to 2025 |
| PSS | Cefazolin | Inj 1 g vial | Cefazolin-AFT | 2391317 | Mar 2024 to 2026 |
| PSS | Cefazolin | Inj 2 g vial | Cefazolin-AFT | 2662876 | Mar 2024 to 2026 |
| PSS | Cefazolin | Inj 500 mg vial | Cefazolin-AFT | 2391325 | Mar 2024 to 2026 |
| PSS | Cefepime | Inj 1 g vial | Cefepime-AFT | 2437066 | Dec 2024 to 2027 |
| PSS | Cefepime | Inj 2 g vial | Cefepime-AFT | 2437074 | Dec 2024 to 2027 |
| PSS | Cefotaxime | Inj 1 g vial | DBL Cefotaxime | 2389762 | Dec 2023 to 2026 |
| PSS | Ceftazidime | Inj 1 g vial | Ceftazidime Kabi | 2581183 | Dec 2023 to 2026 |
| PSS | Ceftriaxone | Inj 1 g vial | Ceftriaxone-AFT | 2428644 | Apr 2023 to 2025 |
| PSS | Ceftriaxone | Inj 2 g vial | Ceftriaxone-AFT | 2653273 | Aug 2023 to 2025 |
| PSS | Ceftriaxone | Inj 500 mg vial | Ceftriaxone-AFT | 2400820 | Apr 2023 to 2025 |
| PSS | Cefuroxime | Inj 1.5 g vial | Cefuroxime Devatis | 2664909 | Jun 2024 to 2026 |
| PSS | Cefuroxime | Inj 750 mg vial | Cefuroxime Devatis | 2664895 | Jun 2024 to 2026 |
| PSS | Celecoxib | Cap 100 mg | Celecoxib Pfizer | 2521164 | Nov 2022 to 2025 |
| PSS | Celecoxib | Cap 200 mg | Celecoxib Pfizer | 2521172 | Nov 2022 to 2025 |
| PSS | Cetirizine hydrochloride | Tab 10 mg | Zista | 2500728 | Sep 2023 to 2026 |
| PSS | Cetomacrogol | Crm BP, 500 g | Cetomacrogol-AFT | 2615509 | Feb 2025 to 2027 |
| PSS | Cetomacrogol with glycerol | Crm 90% with glycerol 10% | Evara | 2642778 | Jul 2023 to 2025 |
| PSS | Cetomacrogol with glycerol | Crm 90% with glycerol 10% | Evara | 2642786 | Jul 2023 to 2025 |
| PSS | Chloramphenicol | Eye oint 1% | Devatis | 2576902 | Dec 2022 to 2025 |
| PSS | Chloramphenicol | Eye drops 0.5% | Chlorsig | 335142 | Sep 2023 to 2025 |
| PSS | Chlorhexidine gluconate | Mouthwash 0.2% | healthE | 2393840 | Jan 2025 to 2027 |
| PSS | Chlortalidone [Chlorthalidone] | Tab 25 mg | Hygroton | 2025779 | Apr 2023 to 2025 |
| PSS | Cinacalcet | Tab 30 mg | Cinacalet Devatis | 2615517 | Dec 2024 to 2027 |
| PSS | Cinacalcet | Tab 60 mg | Cinacalet Devatis | 2615525 | Dec 2024 to 2027 |
| PSS | Ciprofloxacin | Eye drops 0.3% | Ciprofloxacin Teva | 2539144 | Mar 2025 to 2027 |
| PSS | Ciprofloxacin | Tab 250 mg | Ipca-Ciprofloxacin | 2676877 | Nov 2024 to 2026 |
| PSS | Ciprofloxacin | Tab 500 mg | Ipca-Ciprofloxacin | 2676885 | Nov 2024 to 2026 |
| PSS | Ciprofloxacin | Tab 750 mg | Ipca-Ciprofloxacin | 2676893 | Dec 2024 to 2026 |
| PSS | Cisplatin | Inj 1 mg per ml, 100 ml vial | Cisplatin Accord | 2682648 | Dec 2024 to 2027 |
| PSS | Citalopram hydrobromide | Tab 20 mg | Celapram | 2638738 | Mar 2023 to 2025 |
| PSS | Clarithromycin | Inj 500 mg vial | Klacid IV | 2651904 | Jul 2024 to 2026 |
| HSS | Clarithromycin | Tab 250 mg | Klacid | 2606038 | Feb 2022 to 2027 |
| HSS | Clarithromycin | Tab 500 mg | Klacid | 2605295 | Feb 2022 to 2027 |
| PSS | Clindamycin | Cap 150 mg | Dalacin C | 2576392 | Dec 2024 to 2027 |
| PSS | Clindamycin | Inj 150 mg per ml, 4 ml ampoule | Hameln | 2646595 | Aug 2023 to 2025 |
| PSS | Clobetasol propionate | Crm 0.05% | Dermol | 229059 | Jan 2023 to 2025 |
| PSS | Clobetasol propionate | Oint 0.05% | Dermol | 229040 | Jan 2023 to 2025 |
| PSS | Clobetasol propionate | Scalp app 0.05% | Dermol | 772755 | Jan 2023 to 2025 |
| PSS | Clonidine | Patch 2.5 mg, 100 mcg per day | Mylan | 2523078 | Feb 2024 to 2026 |
| PSS | Clonidine | Patch 5 mg, 200 mcg per day | Mylan | 2523086 | Feb 2024 to 2026 |
| PSS | Clonidine | Patch 7.5 mg, 300 mcg per day | Mylan | 2523094 | Feb 2024 to 2026 |
| PSS | Clonidine hydrochloride | Inj 150 mcg per ml, 1 ml ampoule | Catapres | 202266 | Jan 2025 to 2027 |
| PSS | Clonidine hydrochloride | Tab 150 mcg | Catapres | 202274 | Feb 2025 to 2027 |
| PSS | Clonidine hydrochloride | Tab 25 mcg | Clonidine Teva | 2630249 | Nov 2022 to 2025 |
| PSS | Clopidogrel | Tab 75 mg | Arrow - Clopid | 2648954 | May 2023 to 2025 |
| PSS | Clotrimazole | Crm 1% | Clomazol | 2184362 | Apr 2023 to 2025 |
| PSS | Clotrimazole | Vaginal crm 1% with applicator | Clomazol | 2155656 | Apr 2023 to 2025 |
| PSS | Clotrimazole | Vaginal crm 2% with applicator | Clomazol | 2249634 | Apr 2023 to 2025 |
| PSS | Codeine phosphate | Tab 15 mg | Noumed | 2643200 | May 2023 to 2025 |
| PSS | Codeine phosphate | Tab 30 mg | Noumed | 2643219 | Apr 2023 to 2025 |
| PSS | Codeine phosphate | Tab 60 mg | Noumed | 2643227 | Apr 2023 to 2025 |
| PSS | Colchicine | Tab 500 mcg | Colgout | 2200503 | Sep 2022 to 2025 |
| PSS | Colecalciferol | Cap 1.25 mg (50,000 iu) | Vit.D3 | 2523590 | Jun 2024 to 2026 |
| PSS | Compound electrolytes | Powder for oral soln | Electral | 2576937 | Dec 2022 to 2025 |
| PSS | Compound electrolytes with glucose [Dextrose] | Soln with electrolytes | Hydralyte - Lemonade | 2468255 | May 2024 to 2025 |
| PSS | Crotamiton | Crm 10% | Itch-Soothe | 2343614 | Feb 2025 to 2027 |
| PSS | Cyclizine hydrochloride | Tab 50 mg | Nausicalm | 2231220 | Feb 2025 to 2027 |
| PSS | Cyclizine lactate | Inj 50 mg per ml, 1 ml ampoule | Hameln | 2595877 | Dec 2022 to 2025 |
| PSS | Cyclophosphamide | Inj 1 g vial | Endoxan | 2034212 | Feb 2025 to 2027 |
| PSS | Cyclophosphamide | Inj 2 g vial | Endoxan | 2034220 | Feb 2025 to 2027 |
| PSS | Cyclophosphamide | Tab 50 mg | Cyclonex | 2611597 | Dec 2024 to 2027 |
| PSS | Cyproterone acetate with ethinyloestradiol | Tab 2 mg with ethinyloestradiol 35 mcg and 7 inert tablets | Ginet | 2455455 | Feb 2024 to 2026 |
| PSS | Dabigatran | Cap 110 mg | Pradaxa | 2319594 | Jul 2024 to 2026 |
| PSS | Dabigatran | Cap 150 mg | Pradaxa | 2389673 | Jul 2024 to 2026 |
| PSS | Dabigatran | Cap 75 mg | Pradaxa | 2319586 | Jul 2024 to 2026 |
| PSS | Daptomycin | Inj 500 mg vial | Daptomycin Dr Reddy's | 2661616 | Jan 2024 to 2025 |
| PSS | Darunavir | Tab 400 mg | Darunavir Viatris | 2626462 | Feb 2024 to 2026 |
| PSS | Darunavir | Tab 600 mg | Darunavir Viatris | 2626470 | Feb 2024 to 2026 |
| PSS | Dasatinib | Tab 20 mg | Dasatinib-Teva | 2679612 | Mar 2025 to 2027 |
| PSS | Dasatinib | Tab 50 mg | Dasatinib-Teva | 2679620 | Mar 2025 to 2027 |
| PSS | Dasatinib | Tab 70 mg | Dasatinib-Teva | 2679639 | Mar 2025 to 2027 |
| PSS | Desmopressin acetate | Nasal spray 10 mcg per dose | Desmopressin-PH&T | 2198231 | Feb 2024 to 2026 |
| PSS | Dexamethasone | Tab 0.5 mg | Dexmethsone | 2490218 | Feb 2025 to 2027 |
| PSS | Dexamethasone | Tab 4 mg | Dexmethsone | 2490226 | Feb 2025 to 2027 |
| PSS | Dexamethasone phosphate | Inj 4 mg per ml, 1 ml ampoule | Hameln | 2451689 | Feb 2023 to 2025 |
| PSS | Dexamethasone phosphate | Inj 4 mg per ml, 2 ml ampoule | Hameln | 2519143 | Feb 2023 to 2025 |
| PSS | Dexamfetamine sulfate | Tab 5 mg | Noumed Dexamfetamine | 2647516 | Jun 2024 to 2025 |
| PSS | Dexmedetomidine | Inj 100 mcg per ml, 2 ml vial | Dexmedetomidine Viatris | 2660008 | May 2024 to 2026 |
| PSS | Diazepam | Tab 2 mg | Arrow-Diazepam | 2327996 | Mar 2024 to 2026 |
| PSS | Diazepam | Tab 5 mg | Arrow-Diazepam | 2328003 | Mar 2024 to 2026 |
| PSS | Diazepam | Rectal tubes 5 mg | Stesolid | 425877 | Feb 2023 to 2025 |
| PSS | Diclofenac sodium | Tab EC 25 mg | Diclofenac Sandoz | 2355981 | Feb 2025 to 2027 |
| PSS | Diclofenac sodium | Tab EC 50 mg | Diclofenac Sandoz | 2356007 | Feb 2025 to 2027 |
| PSS | Digoxin | Tab 250 mcg | Lanoxin | 2378078 | Jan 2023 to 2025 |
| PSS | Digoxin | Tab 62.5 mcg | Lanoxin PG | 2377012 | Jan 2023 to 2025 |
| PSS | Dihydrocodeine tartrate | Tab long-acting 60 mg | DHC Continus | 772887 | Dec 2022 to 2025 |
| PSS | Diltiazem hydrochloride | Cap long-acting 120 mg | Diltiazem CD Clinect | 2648172 | Jun 2023 to 2025 |
| HSS | Diltiazem hydrochloride | Cap long-acting 180 mg | Cardizem CD | 254584 | Mar 2022 to 2027 |
| HSS | Diltiazem hydrochloride | Cap long-acting 240 mg | Cardizem CD | 254592 | Mar 2022 to 2027 |
| PSS | Dimethicone | Crm 5% tube | healthE Dimethicone 5% | 2374005 | Dec 2022 to 2025 |
| PSS | Dimethicone | Lotn 4% | healthE Dimethicone 4% Lotion | 2351293 | Dec 2022 to 2025 |
| PSS | Dimethicone | Crm 5% pump bottle | healthE Dimethicone 5% | 2373319 | Dec 2022 to 2025 |
| PSS | Diphtheria, tetanus and pertussis vaccine | Inj 2 IU diphtheria toxoid with 20 IU tetanus toxoid, 8 mcg pertussis toxoid, 8 mcg pertussis filamentous haemagglutinin and 2.5 mcg pertactin in 0.5 ml prefilled syringe | Boostrix | 2459418 | Dec 2024 to 2027 |
| PSS | Diphtheria, tetanus, pertussis and polio vaccine | Inj 30 IU diphtheria toxoid with 30IU tetanus toxoid, 25 mcg pertussis toxoid, 25 mcg pertussis filamentous haemagglutinin, 8 mcg pertactin and 80 D-antigen units poliomyelitis virus in 0.5 ml syringe | Infanrix IPV | 2086417 | Dec 2024 to 2027 |
| PSS | Diphtheria, tetanus, pertussis, polio, hepatitis B and haemophilus influenzae type B vaccine | Inj 30IU diphtheria with 40IU tetanus and 25mcg pertussis toxoids, 25mcg pertussis filamentous haemagglutinin, 8mcg pertactin, 80D-AgU polio virus, 10mcg hepatitis B antigen 10mcg H. influenzae type b with tetanus toxoid 20-40mcg in 0.5ml syringe | Infanrix-hexa | 2459396 | Dec 2024 to 2027 |
| PSS | Dobutamine | Inj 12.5 mg per ml, 20 ml ampoule | Dobutamine-hameln | 2450836 | Dec 2024 to 2027 |
| PSS | Docetaxel | Inj 10 mg per ml, 8 ml vial | DBL Docetaxel | 2440830 | Dec 2023 to 2026 |
| PSS | Docusate sodium | Tab 120 mg | Coloxyl | 252859 | Feb 2024 to 2026 |
| PSS | Docusate sodium | Tab 50 mg | Coloxyl | 252832 | Feb 2024 to 2026 |
| PSS | Docusate sodium with sennosides | Tab 50 mg with sennosides 8 mg | Laxsol | 2069482 | Nov 2022 to 2025 |
| PSS | Domperidone | Tab 10 mg | Domperidone Viatris | 2631903 | Jun 2023 to 2025 |
| PSS | Donepezil hydrochloride | Tab 10 mg | Ipca-Donepezil | 2666898 | Jun 2024 to 2026 |
| PSS | Donepezil hydrochloride | Tab 5 mg | Ipca-Donepezil | 2666871 | Jun 2024 to 2026 |
| PSS | Dopamine hydrochloride | Inj 40 mg per ml, 5 ml ampoule | Max Health Ltd | 2374374 | Feb 2025 to 2027 |
| PSS | Dorzolamide with timolol | Eye drops 2% with timolol 0.5% | Dortimopt | 2398354 | Feb 2025 to 2027 |
| PSS | Droperidol | Inj 2.5 mg per ml, 1 ml ampoule | Droperidol Panpharma | 2527138 | Mar 2023 to 2025 |
| PSS | Emtricitabine with tenofovir disoproxil | Tab 200 mg with tenofovir disoproxil 245 mg (300 mg as a maleate) | Tenofovir Disoproxil Emtricitabine Viatr | 2638088 | Jun 2023 to 2025 |
| PSS | Emulsifying ointment | Oint BP | Jaychem | 2377675 | Feb 2024 to 2026 |
| PSS | Emulsifying ointment | Oint BP, 500 g | Emulsifying Ointment ADE | 2597535 | May 2024 to 2026 |
| PSS | Enalapril maleate | Tab 10 mg | Acetec | 2636492 | Feb 2024 to 2025 |
| PSS | Enalapril maleate | Tab 20 mg | Acetec | 2636506 | Feb 2024 to 2025 |
| PSS | Enalapril maleate | Tab 5 mg | Acetec | 2636484 | Feb 2024 to 2025 |
| PSS | Enoxaparin sodium | Inj 100 mg in 1 ml syringe | Clexane | 2581906 | Feb 2025 to 2027 |
| PSS | Enoxaparin sodium | Inj 120 mg in 0.8 ml syringe | Clexane Forte | 2581914 | Feb 2025 to 2027 |
| PSS | Enoxaparin sodium | Inj 150 mg in 1 ml syringe | Clexane Forte | 2581922 | Feb 2025 to 2027 |
| PSS | Enoxaparin sodium | Inj 20 mg in 0.2 ml syringe | Clexane | 2581868 | Feb 2025 to 2027 |
| PSS | Enoxaparin sodium | Inj 40 mg in 0.4 ml syringe | Clexane | 2581876 | Feb 2025 to 2027 |
| PSS | Enoxaparin sodium | Inj 60 mg in 0.6 ml syringe | Clexane | 2581884 | Feb 2025 to 2027 |
| PSS | Enoxaparin sodium | Inj 80 mg in 0.8 ml syringe | Clexane | 2581892 | Feb 2025 to 2027 |
| PSS | Entecavir | Tab 0.5 mg | Entecavir (Rex) | 2654431 | Mar 2024 to 2026 |
| PSS | Ephedrine | Inj 3 mg per ml, 10 ml syringe | Ephedrine Juno | 2544598 | Jun 2024 to 2026 |
| PSS | Ephedrine | Inj 30 mg per ml, 1 ml ampoule | Max Health | 2402874 | Feb 2024 to 2026 |
| PSS | Eplerenone | Tab 25 mg | Inspra | 2619512 | Dec 2024 to 2027 |
| PSS | Eplerenone | Tab 50 mg | Inspra | 2619520 | Dec 2024 to 2027 |
| PSS | Erlotinib | Tab 100 mg | Alchemy | 2641569 | Oct 2024 to 2027 |
| PSS | Erlotinib | Tab 150 mg | Alchemy | 2641550 | Oct 2024 to 2027 |
| PSS | Erythromycin (as lactobionate) | Inj 1 g vial | Erythrocin IV | 2270234 | Dec 2022 to 2025 |
| PSS | Escitalopram | Tab 10 mg | Ipca-Escitalopram | 2661640 | Apr 2024 to 2026 |
| PSS | Escitalopram | Tab 20 mg | Ipca-Escitalopram | 2661659 | Apr 2024 to 2026 |
| PSS | Ethinyloestradiol with levonorgestrel | Tab 20 mcg with levonorgestrel 100 mcg and 7 inert tablets | Lo-Oralcon 20 ED | 2637111 | Aug 2023 to 2025 |
| PSS | Ethinyloestradiol with levonorgestrel | Tab 30 mcg with levonorgestrel 150 mcg and 7 inert tablets | Oralcon 30 ED | 2637138 | Aug 2023 to 2025 |
| PSS | Exemestane | Tab 25 mg | Pfizer Exemestane | 2500647 | Nov 2023 to 2026 |
| PSS | Ezetimibe | Tab 10 mg | Ezetimibe Sandoz | 2545861 | Dec 2023 to 2026 |
| PSS | Febuxostat | Tab 120 mg | Febuxostat (Teva) | 2670364 | Jun 2024 to 2026 |
| PSS | Febuxostat | Tab 80 mg | Febuxostat (Teva) | 2670356 | Jun 2024 to 2026 |
| PSS | Felodipine | Tab long-acting 2.5 mg | Plendil ER | 353760 | Feb 2025 to 2027 |
| PSS | Felodipine | Tab long-acting 10 mg | Felo 10 ER | 2041499 | Feb 2025 to 2027 |
| PSS | Felodipine | Tab long-acting 5 mg | Felo 5 ER | 2041510 | Feb 2025 to 2027 |
| PSS | Fentanyl | Inj 10 mcg per ml, 10 ml syringe | Biomed Fentanyl | 2670690 | Feb 2025 to 2027 |
| PSS | Fentanyl | Inj 10 mcg per ml, 100 ml bag | Biomed | 2594137 | Feb 2024 to 2026 |
| PSS | Fentanyl | Inj 20 mcg per ml, 50 ml syringe | Biomed | 2670704 | Feb 2025 to 2027 |
| PSS | Fentanyl | Patch 100 mcg per hour | Fentanyl Sandoz | 2472910 | Dec 2024 to 2027 |
| PSS | Fentanyl | Patch 12.5 mcg per hour | Fentanyl Sandoz | 2472872 | Dec 2024 to 2027 |
| PSS | Fentanyl | Patch 25 mcg per hour | Fentanyl Sandoz | 2472880 | Dec 2024 to 2027 |
| PSS | Fentanyl | Patch 50 mcg per hour | Fentanyl Sandoz | 2472899 | Dec 2024 to 2027 |
| PSS | Fentanyl | Patch 75 mcg per hour | Fentanyl Sandoz | 2472902 | Dec 2024 to 2027 |
| PSS | Ferrous fumarate | Tab 200 mg (65 mg elemental) | Ferro-tab | 2162156 | Feb 2025 to 2027 |
| PSS | Ferrous fumarate with folic acid | Tab 310 mg (100 mg elemental) with folic acid 350 mcg | Ferro-F-Tabs | 2615584 | Dec 2024 to 2027 |
| PSS | Ferrous sulfate | Oral liq 30 mg (6 mg elemental) per ml | Ferodan | 2259087 | Jan 2023 to 2025 |
| PSS | Ferrous sulfate | Tab long-acting 325 mg (105 mg elemental) | Ferrograd | 2534819 | Jan 2023 to 2025 |
| PSS | Filgrastim | Inj 300 mcg in 0.5 ml prefilled syringe | Nivestim | 2561956 | Dec 2024 to 2027 |
| PSS | Filgrastim | Inj 480 mcg in 0.5 ml prefilled syringe | Nivestim | 2561964 | Dec 2024 to 2027 |
| PSS | Finasteride | Tab 5 mg | Ricit | 2522756 | Dec 2023 to 2026 |
| PSS | Flecainide acetate | Cap long-acting 100 mg | Flecainide Controlled Release Teva | 2567113 | Aug 2023 to 2026 |
| PSS | Flecainide acetate | Cap long-acting 200 mg | Flecainide Controlled Release Teva | 2567121 | Aug 2023 to 2026 |
| PSS | Flecainide acetate | Tab 50 mg | Flecainide BNM | 2567695 | Dec 2023 to 2026 |
| PSS | Flucloxacillin | Inj 1 g vial | Flucil | 2523108 | Feb 2024 to 2026 |
| PSS | Flucloxacillin | Inj 250 mg vial | Flucloxin | 331848 | Jul 2024 to 2026 |
| PSS | Flucloxacillin | Inj 500 mg vial | Flucloxin | 331856 | Jul 2024 to 2026 |
| PSS | Flucloxacillin | Grans for oral liq 25 mg per ml | AFT | 2431424 | Feb 2025 to 2027 |
| PSS | Flucloxacillin | Grans for oral liq 50 mg per ml | AFT | 2431432 | Feb 2025 to 2027 |
| PSS | Fluconazole | Cap 150 mg | Mylan | 2149079 | Dec 2023 to 2026 |
| PSS | Fluconazole | Cap 200 mg | Mylan | 2149052 | Dec 2023 to 2026 |
| PSS | Fluconazole | Cap 50 mg | Mylan | 2149060 | Dec 2023 to 2026 |
| PSS | Fludarabine phosphate | Inj 50 mg vial | Fludarabine Ebewe | 2386933 | Jan 2023 to 2025 |
| PSS | Fludrocortisone acetate | Tab 100 mcg | Florinef | 204951 | Dec 2022 to 2025 |
| PSS | Flumazenil | Inj 0.1 mg per ml, 5 ml ampoule | Flumazenil-Baxter | 2599481 | Dec 2024 to 2027 |
| PSS | Fluorouracil | Inj 50 mg per ml, 20 ml vial | Fluorouracil Accord | 2618435 | Dec 2024 to 2027 |
| PSS | Fluorouracil | Inj 50 mg per ml, 100 ml vial | Fluorouracil Accord | 2618427 | Dec 2024 to 2027 |
| PSS | Fluorouracil sodium | Crm 5% | Efudix | 253065 | Dec 2024 to 2027 |
| PSS | Fluoxetine hydrochloride | Cap 20 mg | Arrow-Fluoxetine | 2450860 | Jun 2023 to 2025 |
| PSS | Fluoxetine hydrochloride | Tab dispersible 20 mg, scored | Fluox | 2618575 | Feb 2023 to 2025 |
| HSS | Folic acid | Tab 5 mg | Folic Acid Viatris | 2633450 | Mar 2023 to 2027 |
| PSS | Fosfomycin | Powder for oral solution, 3 g sachet | UroFos | 2538210 | Apr 2025 to 2027 |
| PSS | Furosemide [Frusemide] | Inj 10 mg per ml, 2 ml ampoule | Furosemide-Baxter | 2599503 | Jan 2023 to 2025 |
| PSS | Furosemide [Frusemide] | Tab 40 mg | IPCA-Frusemide | 2618699 | Feb 2025 to 2027 |
| HSS | Gabapentin | Cap 100 mg | Nupentin | 2422751 | Feb 2022 to 2027 |
| HSS | Gabapentin | Cap 300 mg | Nupentin | 2422778 | Feb 2022 to 2027 |
| HSS | Gabapentin | Cap 400 mg | Nupentin | 2422786 | Feb 2022 to 2027 |
| PSS | Gemcitabine Hydrochloride | Inj 43.3 mg per ml (equivalent to 38 mg per ml gemcitabine), 26.3 ml vial | DBL Gemcitabine | 2521423 | Jun 2024 to 2026 |
| PSS | Glatiramer acetate | Inj 40 mg prefilled syringe | Copaxone | 2545349 | Oct 2022 to 2025 |
| PSS | Gliclazide | Tab 80 mg | Glizide | 2280647 | Feb 2024 to 2026 |
| PSS | Glipizide | Tab 5 mg | Minidiab | 2091755 | Mar 2025 to 2027 |
| PSS | Glucose [Dextrose] | Inj 50%, 10 ml ampoule | Biomed | 2243296 | Feb 2024 to 2026 |
| PSS | Glucose [Dextrose] | Inj 50%, 90 ml bottle | Biomed | 2245833 | Feb 2024 to 2026 |
| PSS | Glycerol | Suppos 2.8/4.0 g | Lax-suppositories Glycerol | 2637103 | Feb 2023 to 2025 |
| PSS | Glycopyrronium bromide | Inj 200 mcg per ml, 1 ml ampoule | Robinul | 2254484 | Sep 2023 to 2025 |
| PSS | Goserelin | Implant 10.8 mg, syringe | Zoladex | 362107 | Apr 2024 to 2026 |
| PSS | Goserelin | Implant 3.6 mg, syringe | Zoladex | 678066 | Apr 2024 to 2026 |
| PSS | Granisetron | Inj 1 mg per ml, 3 ml ampoule | Deva | 2554186 | Feb 2024 to 2026 |
| PSS | Haemophilus influenzae type B vaccine | Inj 10 mcg vial with diluent syringe | Act-HIB | 2404699 | Dec 2024 to 2026 |
| PSS | Heparin sodium | Inj 5,000 iu per ml, 5 ml vial | Heparin Sodium Panpharma | 2651815 | Jul 2023 to 2025 |
| PSS | Hepatitis A vaccine | Inj 1440 ELISA units in 1 ml syringe | Havrix 1440 | 2061937 | Dec 2024 to 2027 |
| PSS | Hepatitis A vaccine | Inj 720 ELISA units in 0.5 ml syringe | Havrix Junior | 793582 | Dec 2024 to 2027 |
| PSS | Hepatitis B recombinant vaccine | Inj 10 mcg per 0.5 ml prefilled syringe | Engerix-B | 2601044 | Dec 2024 to 2027 |
| PSS | Hepatitis B recombinant vaccine | Inj 20 mcg per 1 ml prefilled syringe | Engerix-B | 2534533 | Dec 2024 to 2027 |
| PSS | Human papillomavirus (6, 11, 16, 18, 31, 33, 45, 52 and 58) vaccine [HPV] | Inj 270 mcg in 0.5 ml syringe | Gardasil 9 | 2506254 | Dec 2024 to 2027 |
| PSS | Hydrocortisone | Crm 1%, 30 g | Ethics | 2646587 | Apr 2023 to 2025 |
| PSS | Hydrocortisone | Crm 1%, 500 g | Noumed | 2645580 | Aug 2023 to 2025 |
| PSS | Hydrocortisone | Inj 100 mg vial | Solu-Cortef | 265284 | Dec 2024 to 2027 |
| PSS | Hydrocortisone and paraffin liquid and lanolin | Lotn 1% with paraffin liquid 15.9% and lanolin 0.6% | DP Lotn HC | 716294 | Jun 2024 to 2026 |
| PSS | Hydrocortisone with miconazole | Crm 1% with miconazole nitrate 2% | Micreme H | 704733 | Feb 2025 to 2027 |
| PSS | Hydroxyurea [hydroxycarbamide] | Cap 500 mg | Devatis | 2593246 | Dec 2023 to 2026 |
| PSS | Hyoscine butylbromide | Inj 20 mg, 1 ml ampoule | Spazmol | 2656027 | Dec 2023 to 2026 |
| PSS | Hyoscine butylbromide | Tab 10 mg | Hyoscine Butylbromide (Adiramedica) | 2687224 | Apr 2025 to 2027 |
| PSS | Ibuprofen | Oral liq 20 mg per ml | Ethics | 2551985 | Apr 2025 to 2027 |
| HSS | Ibuprofen | Tab 200 mg - 1,000 tablet pack | Relieve | 2526212 | Feb 2021 to 2026 |
| PSS | Ibuprofen | Tab long-acting 800 mg | Ibuprofen SR BNM | 2690276 | Apr 2025 to 2027 |
| PSS | Iloprost | Nebuliser soln 10 mcg per ml, 2 ml | Vebulis | 2643006 | Mar 2023 to 2025 |
| PSS | Imatinib mesilate | Cap 100 mg | Imatinib-Rex | 2594315 | Dec 2023 to 2026 |
| PSS | Imatinib mesilate | Cap 400 mg | Imatinib-Rex | 2594323 | Dec 2023 to 2026 |
| PSS | Indapamide | Tab 2.5 mg | Dapa-Tabs | 2356406 | Feb 2024 to 2026 |
| HSS | Infliximab | Inj 100 mg | Remicade | 2016710 | Sep 2020 to 2025 |
| PSS | Intra-uterine device | IUD 29.1 mm length x 23.2 mm width | Choice 380 7med Nsha Silver/copper Short | 2643758 | Nov 2024 to 2025 |
| PSS | Intra-uterine device | IUD 33.6 mm length x 29.9 mm width | TCu 380 Plus Normal | 2688484 | Nov 2024 to 2025 |
| PSS | Intra-uterine device | IUD 35.5 mm length x 19.6 mm width | Cu 375 Standard | 2688476 | Nov 2024 to 2025 |
| PSS | Isoniazid with rifampicin | Tab 100 mg with rifampicin 150 mg | Rifinah | 251232 | Feb 2025 to 2027 |
| PSS | Isoniazid with rifampicin | Tab 150 mg with rifampicin 300 mg | Rifinah | 251240 | Feb 2025 to 2027 |
| PSS | Isosorbide mononitrate | Tab 20 mg | Ismo 20 | 214833 | Feb 2024 to 2026 |
| PSS | Isosorbide mononitrate | Tab long-acting 40 mg | Ismo 40 Retard | 2447355 | Feb 2024 to 2026 |
| PSS | Isosorbide mononitrate | Tab long-acting 60 mg | Duride | 2202964 | Feb 2024 to 2026 |
| PSS | Isotretinoin | Cap 10 mg | Oratane | 2400286 | Dec 2024 to 2027 |
| PSS | Isotretinoin | Cap 20 mg | Oratane | 2400278 | Dec 2024 to 2027 |
| PSS | Isotretinoin | Cap 5 mg | Oratane | 2339161 | Dec 2024 to 2027 |
| PSS | Ispaghula (psyllium) husk | Powder for oral soln | Konsyl-D | 2358727 | Feb 2024 to 2026 |
| PSS | Ketoconazole | Shampoo 2% | Sebizole | 461504 | May 2024 to 2026 |
| PSS | Lactulose | Oral liq 10 g per 15 ml | Laevolac | 2440210 | Apr 2023 to 2025 |
| PSS | Lamivudine | Tab 100 mg | Zetlam | 2399369 | Feb 2024 to 2026 |
| PSS | Lamivudine | Tab 150 mg | Lamivudine Viatris | 2638045 | Feb 2024 to 2026 |
| PSS | Lansoprazole | Cap 15 mg | Lanzol Relief | 2482533 | Feb 2025 to 2027 |
| PSS | Lansoprazole | Cap 30 mg | Lanzol Relief | 2482541 | Feb 2025 to 2027 |
| PSS | Latanoprost | Eye drops 0.005% | Teva | 2553139 | Mar 2025 to 2027 |
| PSS | Latanoprost with timolol | Eye drops 0.005% with timolol 0.5% | Arrow - Lattim | 2597861 | Mar 2024 to 2026 |
| PSS | Leflunomide | Tab 10 mg | Arava | 306843 | Dec 2023 to 2026 |
| PSS | Leflunomide | Tab 20 mg | Arava | 369470 | Dec 2023 to 2026 |
| PSS | Lenalidomide (Viatris) | Cap 10 mg | Lenalidomide Viatris | 2673533 | Feb 2025 to 31~Jan~2028 |
| PSS | Lenalidomide (Viatris) | Cap 15 mg | Lenalidomide Viatris | 2673541 | Feb 2025 to 31~Jan~2028 |
| PSS | Lenalidomide (Viatris) | Cap 25 mg | Lenalidomide Viatris | 2673568 | Feb 2025 to 31~Jan~2028 |
| PSS | Lenalidomide (Viatris) | Cap 5 mg | Lenalidomide Viatris | 2673525 | Feb 2025 to 31~Jan~2028 |
| PSS | Letrozole | Tab 2.5 mg | Letrole | 2656655 | Dec 2024 to 2027 |
| PSS | Levodopa with carbidopa | Tab 100 mg with carbidopa 25 mg | Sinemet | 2429985 | Feb 2025 to 2027 |
| PSS | Levodopa with carbidopa | Tab long-acting 200 mg with carbidopa 50 mg | Sinemet CR | 2430002 | Feb 2025 to 2027 |
| PSS | Levodopa with carbidopa | Tab 250 mg with carbidopa 25 mg | Sinemet | 2429993 | Feb 2025 to 2027 |
| PSS | Levomepromazine hydrochloride | Inj 25 mg per ml, 1 ml ampoule | Wockhardt | 2501902 | Apr 2023 to 2025 |
| PSS | Levonorgestrel | Subdermal implant (2 x 75 mg rods) | Jadelle | 2265532 | Dec 2023 to 2026 |
| PSS | Levonorgestrel | Tab 1.5 mg | Levonorgestrel BNM | 2645424 | Jun 2023 to 2025 |
| PSS | Levosimendan | Inj 2.5 mg per ml, 5 ml vial | Simdax | 2304236 | Nov 2024 to 2027 |
| PSS | Lidocaine [Lignocaine] hydrochloride | Gel 2%, 11 ml urethral syringe | Instillagel Lido | 2580497 | Jan 2023 to 2025 |
| PSS | Lidocaine [Lignocaine] hydrochloride | Spray 10% | Xylocaine | 761125 | Jan 2023 to 2025 |
| PSS | Lidocaine [Lignocaine] hydrochloride with adrenaline | Inj 1% with adrenaline 1:100,000, 5 ml ampoule | Xylocaine | 2120577 | Jan 2023 to 2025 |
| PSS | Linezolid | Inj 2 mg per ml, 300 ml bottle | Linezolid Kabi | 2556766 | Dec 2024 to 2027 |
| PSS | Linezolid | Tab 600 mg | Zyvox | 2058758 | Dec 2024 to 2027 |
| PSS | Lisinopril | Tab 10 mg | Ethics Lisinopril | 2352443 | Oct 2022 to 2025 |
| PSS | Lisinopril | Tab 10 mg | Teva Lisinopril | 2643677 | Oct 2022 to 2025 |
| PSS | Lisinopril | Tab 20 mg | Ethics Lisinopril | 2352451 | Oct 2022 to 2025 |
| PSS | Lisinopril | Tab 20 mg | Teva Lisinopril | 2643685 | Oct 2022 to 2025 |
| PSS | Lisinopril | Tab 5 mg | Ethics Lisinopril | 2352435 | Oct 2022 to 2025 |
| PSS | Lisinopril | Tab 5 mg | Teva Lisinopril | 2643669 | Oct 2022 to 2025 |
| PSS | Lithium carbonate | Tab long-acting 400 mg | Priadel | 260851 | Feb 2025 to 2027 |
| PSS | Loperamide hydrochloride | Cap 2 mg | Diamide Relief | 2365545 | Jan 2023 to 2025 |
| PSS | Lopinavir with ritonavir | Tab 200 mg with ritonavir 50 mg | Lopinavir/Ritonavir Mylan | 2613549 | Feb 2025 to 2027 |
| PSS | Loratadine | Tab 10 mg | Lorafix | 2443996 | Feb 2023 to 2025 |
| PSS | Lorazepam | Tab 1 mg | Ativan | 2139022 | Feb 2025 to 2027 |
| PSS | Lorazepam | Tab 2.5 mg | Ativan | 250120 | Feb 2025 to 2027 |
| PSS | Losartan potassium | Tab 100 mg | Losartan Actavis | 2466880 | Mar 2024 to 2026 |
| PSS | Losartan potassium | Tab 12.5 mg | Losartan Actavis | 2466856 | Mar 2024 to 2026 |
| PSS | Losartan potassium | Tab 25 mg | Losartan Actavis | 2466864 | Mar 2024 to 2026 |
| PSS | Losartan potassium | Tab 50 mg | Losartan Actavis | 2466872 | Mar 2024 to 2026 |
| PSS | Losartan potassium with hydrochlorothiazide | Tab 50 mg with hydrochlorothiazide 12.5 mg | Arrow-Losartan & Hydrochlorothiazide | 2390620 | Jan 2023 to 2025 |
| PSS | Macrogol 3350 with potassium chloride and sodium chloride | Powder for oral soln 755.68 mg with potassium chloride 10.55 mg, sodium chloride 37.33 mg and sodium sulphate 80.62 mg per g, 70 g sachet | Glycoprep Orange | 2637987 | Feb 2025 to 2027 |
| PSS | Macrogol 3350 with potassium chloride and sodium chloride | Powder for oral soln 755.68 mg with potassium chloride 10.55 mg, sodium chloride 37.33 mg and sodium sulphate 80.62 mg per g, 70 g sachet | Glycoprep Orange | 2637995 | Feb 2025 to 2027 |
| PSS | Macrogol 3350 with potassium chloride and sodium chloride with/without sodium sulfate, sodium ascorbate, ascorbic acid | Powd for oral soln 100g with potassium chloride 1g, sodium chloride 2g and sodium sulfate 9g per sach(1), powd for oral soln 40g with potassium chloride 1.2g and sodium chloride 3.2g per sach(1) and powd for oral soln ascorbic acid 7.54g and sodium ascorbate 48.11g per sach(1) | Plenvu | 2569671 | Oct 2023 to 2026 |
| PSS | Macrogol 3350 with potassium chloride, sodium bicarbonate and sodium chloride | Powder for oral soln 13.125 g with potassium chloride 46.6 mg, sodium bicarbonate 178.5 mg and sodium chloride 350.7 mg | Molaxole | 2519887 | Feb 2024 to 2026 |
| PSS | Magnesium sulphate | Inj 2 mmol per ml, 5 ml ampoule | Martindale | 2406438 | Jun 2024 to 2026 |
| PSS | Measles, mumps and rubella vaccine | Injection, measles virus 1,000 CCID50, mumps virus 5,012 CCID50, Rubella virus 1,000 CCID50; prefilled syringe/ampoule of diluent 0.5 ml | Priorix | 2509369 | Dec 2024 to 2027 |
| PSS | Mebendazole | Tab 100 mg | Vermox | 258040 | Dec 2024 to 2027 |
| PSS | Mebeverine hydrochloride | Tab 135 mg | Colofac | 2535297 | Dec 2023 to 2026 |
| PSS | Melatonin | Tab modified-release 2 mg | Vigisom | 2612593 | Dec 2024 to 2027 |
| PSS | Melphalan | Inj 50 mg vial | Melpha | 2647699 | Dec 2023 to 2026 |
| PSS | Meningococcal (A, C, Y and W-135) conjugate vaccine | Inj 10 mcg of each meningococcal polysaccharide conjugated to a total of approximately 55 mcg of tetanus toxoid carrier per 0.5 ml vial | MenQuadfi | 2649012 | Dec 2024 to 2027 |
| PSS | Mercaptopurine | Tab 50 mg | Puri-nethol | 261270 | Dec 2022 to 2025 |
| PSS | Meropenem | Inj 1 g vial | Meropenem-AFT | 2591316 | Jun 2024 to 2026 |
| PSS | Meropenem | Inj 500 mg vial | Meropenem-AFT | 2591308 | Jun 2024 to 2026 |
| PSS | Metaraminol | Inj 10 mg per ml, 1 ml ampoule | Torbay | 2482983 | Feb 2024 to 2026 |
| HSS | Metformin hydrochloride | Tab immediate-release 500 mg | Metformin Viatris | 2628031 | Mar 2023 to 2027 |
| HSS | Metformin hydrochloride | Tab immediate-release 850 mg | Metformin Viatris | 2628058 | Aug 2023 to 2027 |
| PSS | Methadone hydrochloride | Oral liq 10 mg per ml | Biodone Extra Forte | 412325 | Feb 2025 to 2027 |
| PSS | Methadone hydrochloride | Oral liq 2 mg per ml | Biodone | 361372 | Feb 2025 to 2027 |
| PSS | Methadone hydrochloride | Oral liq 5 mg per ml | Biodone Forte | 412341 | Feb 2025 to 2027 |
| PSS | Methadone hydrochloride | Tab 5 mg | Methadone BNM | 2639823 | Feb 2023 to 2025 |
| PSS | Methenamine (Hexamine) hippurate | Tab 1 g | Hiprex | 2671077 | Feb 2023 to 2025 |
| PSS | Methotrexate | Inj 10 mg prefilled syringe | Methotrexate Sandoz | 2445840 | Feb 2025 to 2027 |
| PSS | Methotrexate | Inj 15 mg prefilled syringe | Methotrexate Sandoz | 2445859 | Feb 2025 to 2027 |
| PSS | Methotrexate | Inj 20 mg prefilled syringe | Methotrexate Sandoz | 2445867 | Feb 2025 to 2027 |
| PSS | Methotrexate | Inj 25 mg prefilled syringe | Methotrexate Sandoz | 2445875 | Feb 2025 to 2027 |
| PSS | Methotrexate | Inj 30 mg prefilled syringe | Methotrexate Sandoz | 2445883 | Feb 2025 to 2027 |
| PSS | Methotrexate | Inj 100 mg per ml, 50 ml vial | Methotrexate Ebewe | 2215683 | Dec 2023 to 2026 |
| PSS | Methotrexate | Inj 7.5 mg prefilled syringe | Methotrexate Sandoz | 2445832 | Feb 2025 to 2027 |
| PSS | Methotrexate | Tab 10 mg | Trexate | 2537079 | Dec 2024 to 2027 |
| PSS | Methotrexate | Tab 2.5 mg | Trexate | 2537060 | Dec 2024 to 2027 |
| PSS | Methylprednisolone aceponate | Crm 0.1% | Advantan | 389439 | Feb 2024 to 2026 |
| PSS | Methylprednisolone aceponate | Oint 0.1% | Advantan | 388874 | Feb 2024 to 2026 |
| PSS | Metoclopramide hydrochloride | Inj 5 mg per ml, 2 ml ampoule | Baxter | 2625873 | Dec 2022 to 2025 |
| PSS | Metoclopramide hydrochloride | Tab 10 mg | Metoclopramide Actavis 10 | 2528878 | Mar 2024 to 2026 |
| PSS | Metoprolol succinate | Tab long-acting 190 mg | Myloc CR | 2650738 | Apr 2024 to 2026 |
| PSS | Metoprolol succinate | Tab long-acting 23.75 mg | Myloc CR | 2650681 | Apr 2024 to 2026 |
| PSS | Metoprolol succinate | Tab long-acting 47.5 mg | Myloc CR | 2650703 | Apr 2024 to 2026 |
| PSS | Metoprolol succinate | Tab long-acting 95 mg | Myloc CR | 2650711 | Apr 2024 to 2026 |
| HSS | Metoprolol tartrate | Tab 100 mg | IPCA-Metoprolol | 2618680 | Mar 2022 to 2027 |
| HSS | Metoprolol tartrate | Tab 50 mg | IPCA-Metoprolol | 2618672 | Mar 2022 to 2027 |
| PSS | Metronidazole | Inj 5 mg per ml, 100 ml bag | Baxter | 2548305 | Dec 2023 to 2026 |
| PSS | Metronidazole | Tab 200 mg | Metronidamed | 2684446 | Mar 2025 to 2027 |
| PSS | Metronidazole | Tab 400 mg | Metronidamed | 2684454 | Mar 2025 to 2027 |
| PSS | Miconazole | Oral gel 20 mg per g | Decozol | 2405008 | Feb 2025 to 2027 |
| PSS | Miconazole nitrate | Crm 2% | Multichem | 2184354 | May 2024 to 2026 |
| PSS | Midazolam | Inj 1 mg per ml, 5 ml ampoule | Midazolam-Baxter | 2599279 | May 2025 to 2027 |
| PSS | Midazolam | Inj 5 mg per ml, 3 ml ampoule | Midazolam-Baxter | 2599260 | May 2025 to 2027 |
| PSS | Midodrine | Tab 2.5 mg | Midodrine Medsurge | 2632063 | Feb 2025 to 2027 |
| PSS | Midodrine | Tab 5 mg | Midodrine Medsurge | 2632071 | Feb 2025 to 2027 |
| PSS | Milrinone | Inj 1 mg per ml, 10 ml ampoule | Milrinone-Baxter | 2603047 | Dec 2024 to 2027 |
| PSS | Moclobemide | Tab 150 mg | Aurorix | 2602385 | Feb 2025 to 2027 |
| PSS | Moclobemide | Tab 300 mg | Aurorix | 2602393 | Feb 2025 to 2027 |
| PSS | Mometasone furoate | Crm 0.1% | Elocon Alcohol Free | 218375 | Feb 2025 to 2027 |
| PSS | Mometasone furoate | Crm 0.1% | Elocon Alcohol Free | 2395738 | Feb 2025 to 2027 |
| PSS | Mometasone furoate | Oint 0.1% | Elocon | 218383 | Feb 2025 to 2027 |
| PSS | Mometasone furoate | Oint 0.1% | Elocon | 2395746 | Feb 2025 to 2027 |
| PSS | Mometasone furoate | Lotn 0.1% | Elocon | 2177633 | Feb 2025 to 2027 |
| PSS | Montelukast | Tab 10 mg | Montelukast Viatris | 2643634 | Sep 2023 to 2025 |
| PSS | Montelukast | Tab 4 mg | Montelukast Viatris | 2643618 | Sep 2023 to 2025 |
| PSS | Montelukast | Tab 5 mg | Montelukast Viatris | 2643626 | Jul 2023 to 2025 |
| PSS | Morphine sulphate | Cap long-acting 10 mg | m-Eslon | 2106469 | Apr 2023 to 2025 |
| PSS | Morphine sulphate | Cap long-acting 100 mg | m-Eslon | 2106507 | Apr 2023 to 2025 |
| PSS | Morphine sulphate | Cap long-acting 30 mg | m-Eslon | 2106485 | Apr 2023 to 2025 |
| PSS | Morphine sulphate | Cap long-acting 60 mg | m-Eslon | 2106493 | Apr 2023 to 2025 |
| PSS | Morphine sulphate | Inj 1 mg per ml, 100 ml bag | Biomed | 2526034 | Feb 2024 to 2026 |
| PSS | Morphine sulphate | Inj 1 mg per ml, 10 ml syringe | Biomed | 2526018 | Feb 2024 to 2026 |
| PSS | Morphine sulphate | Inj 1 mg per ml, 50 ml syringe | Biomed | 2526026 | Feb 2024 to 2026 |
| PSS | Morphine sulphate | Inj 10 mg per ml, 1 ml ampoule | Medsurge | 2602458 | Mar 2023 to 2025 |
| PSS | Morphine sulphate | Inj 15 mg per ml, 1 ml ampoule | Medsurge | 2602466 | Mar 2023 to 2025 |
| PSS | Morphine sulphate | Inj 30 mg per ml, 1 ml ampoule | Medsurge | 2602474 | Mar 2023 to 2025 |
| PSS | Morphine sulphate | Inj 5 mg per ml, 1 ml ampoule | Medsurge | 2602431 | Mar 2023 to 2025 |
| PSS | Moxifloxacin | Inj 1.6 mg per ml, 250 ml bottle | Moxifloxacin Kabi | 2577062 | Feb 2024 to 2026 |
| PSS | Multivitamins | Tab (BPC cap strength) | Mvite | 2642247 | Feb 2023 to 2025 |
| HSS | Nadolol | Tab 40 mg | Nadolol BNM | 2621118 | Mar 2022 to 2027 |
| HSS | Nadolol | Tab 40 mg | Nadolol BNM | 2647540 | Mar 2022 to 2027 |
| HSS | Nadolol | Tab 80 mg | Nadolol BNM | 2621126 | Mar 2022 to 2027 |
| HSS | Nadolol | Tab 80 mg | Nadolol BNM | 2647559 | Mar 2022 to 2027 |
| PSS | Naloxone hydrochloride | Inj 400 mcg per ml, 1 ml ampoule | DBL Naloxone Hydrochloride | 788457 | Apr 2025 to 2027 |
| PSS | Naltrexone hydrochloride | Tab 50 mg | Naltraccord | 2380374 | Dec 2023 to 2026 |
| PSS | Naphazoline hydrochloride | Eye drops 0.1% | Albalon | 200182 | Jan 2025 to 2027 |
| PSS | Naproxen | Tab long-acting 1 g | Naprosyn SR 1000 | 2518619 | Feb 2025 to 2027 |
| PSS | Naproxen | Tab 250 mg | Noflam 250 | 2654458 | Feb 2025 to 2027 |
| PSS | Naproxen | Tab 500 mg | Noflam 500 | 2654466 | Feb 2025 to 2027 |
| PSS | Naproxen | Tab long-acting 750 mg | Naprosyn SR 750 | 2518627 | Feb 2025 to 2027 |
| PSS | Neostigmine metilsulfate | Inj 2.5 mg per ml, 1 ml ampoule | Max Health | 2599996 | Feb 2025 to 2027 |
| PSS | Nevirapine | Tab 200 mg | Nevirapine Viatris | 2640023 | Feb 2025 to 2027 |
| PSS | Nicorandil | Tab 10 mg | Max Health | 2669242 | May 2024 to 2025 |
| PSS | Nicorandil | Tab 20 mg | Max Health | 2669250 | May 2024 to 2025 |
| PSS | Nimodipine | Inj 0.2 mg per ml, 50 ml vial | Nimotop | 2663937 | May 2024 to 2025 |
| PSS | Nimodipine | Tab 30 mg | Nimotop | 818461 | Dec 2022 to 2025 |
| PSS | Nitrofurantoin | Cap modified-release 100 mg | Macrobid | 2493624 | Dec 2023 to 2026 |
| PSS | Nitrofurantoin | Tab 50 mg | Nifuran | 254738 | Dec 2024 to 2027 |
| PSS | Noradrenaline | Inj 1 mg per ml, 4 ml ampoule | Noradrenaline BNM | 2519879 | Feb 2024 to 2025 |
| PSS | Nortriptyline hydrochloride | Tab 10 mg | Norpress | 2090678 | May 2023 to 2025 |
| PSS | Nortriptyline hydrochloride | Tab 25 mg | Norpress | 2312441 | May 2023 to 2025 |
| PSS | Nystatin | Vaginal crm 100,000 u per 5 g with applicator(s) | Nilstat | 254908 | Feb 2024 to 2026 |
| PSS | Nystatin | Oral liquid 100,000 u per ml | Nilstat | 254851 | Feb 2024 to 2026 |
| PSS | Octreotide | Inj depot 10 mg prefilled syringe | Sandostatin LAR | 2150832 | Dec 2024 to 2027 |
| PSS | Octreotide | Inj depot 20 mg prefilled syringe | Sandostatin LAR | 2150840 | Dec 2024 to 2027 |
| PSS | Octreotide | Inj depot 30 mg prefilled syringe | Sandostatin LAR | 2150859 | Dec 2024 to 2027 |
| PSS | Oestradiol | Gel (transdermal) 0.06% (750 mcg/actuation) | Estrogel | 2656191 | Nov 2024 to 31~Oct~2027 |
| PSS | Oestriol | Crm 1 mg per g with applicator | Ovestin | 767441 | Feb 2024 to 2026 |
| PSS | Oestriol | Pessaries 500 mcg | Ovestin | 767468 | Feb 2024 to 2026 |
| PSS | Oestriol | Tab 2 mg | Ovestin | 767476 | Feb 2024 to 2026 |
| PSS | Oil in water emulsion | Crm, 500 g | Fatty Emulsion Cream (Evara) | 2491311 | Apr 2025 to 2027 |
| PSS | Oil in water emulsion | Crm, 100 g | Fatty Emulsion Cream (Evara) | 2684497 | Apr 2025 to 2027 |
| PSS | Olanzapine | Tab 10 mg | Zypine | 2439875 | Aug 2024 to 2026 |
| PSS | Olanzapine | Tab 10 mg | Zypine | 2651092 | Aug 2024 to 2026 |
| PSS | Olanzapine | Tab orodispersible 10 mg | Zypine ODT | 2439840 | Feb 2024 to 2026 |
| PSS | Olanzapine | Tab 2.5 mg | Zypine | 2439859 | Aug 2024 to 2026 |
| PSS | Olanzapine | Tab 2.5 mg | Zypine | 2651076 | Aug 2024 to 2026 |
| PSS | Olanzapine | Tab 5 mg | Zypine | 2439867 | Aug 2024 to 2026 |
| PSS | Olanzapine | Tab 5 mg | Zypine | 2651084 | Aug 2024 to 2026 |
| PSS | Olanzapine | Tab orodispersible 5 mg | Zypine ODT | 2439832 | Feb 2024 to 2026 |
| PSS | Olopatadine | Eye drops 0.1% | Olopatadine Teva | 2588048 | Dec 2022 to 2025 |
| PSS | Omeprazole | Cap 10 mg | Omeprazole actavis 10 | 2604930 | Mar 2024 to 2026 |
| PSS | Omeprazole | Cap 20 mg | Omeprazole actavis 20 | 2604949 | Mar 2024 to 2026 |
| PSS | Omeprazole | Cap 40 mg | Omeprazole actavis 40 | 2604957 | Mar 2024 to 2026 |
| PSS | Omeprazole | Inj 40 mg vial | Omezol IV | 2503387 | Jan 2023 to 2025 |
| PSS | Omeprazole | Inj 40 mg ampoule with diluent | Dr Reddy's Omeprazole | 2310201 | Jan 2023 to 2025 |
| PSS | Ondansetron | Inj 2 mg per ml, 2 ml ampoule | Ondansetron-AFT | 2604752 | Mar 2023 to 2025 |
| PSS | Ondansetron | Inj 2 mg per ml, 4 ml ampoule | Ondansetron-AFT | 2604760 | Mar 2023 to 2025 |
| PSS | Ondansetron | Tab 4 mg | Periset | 2648024 | Aug 2023 to 2025 |
| PSS | Ondansetron | Tab dispersible 4 mg | Periset ODT | 2656868 | Mar 2024 to 2026 |
| PSS | Ondansetron | Tab 8 mg | Periset | 2648032 | Aug 2023 to 2025 |
| PSS | Ondansetron | Tab dispersible 8 mg | Periset ODT | 2656876 | Mar 2024 to 2026 |
| PSS | Ornidazole | Tab 500 mg | Arrow-Ornidazole | 2385325 | Mar 2025 to 2027 |
| PSS | Orphenadrine citrate | Tab 100 mg | Norflex | 2645564 | Feb 2025 to 2027 |
| PSS | Oxycodone hydrochloride | Inj 10 mg per ml, 1 ml ampoule | Hameln | 2631172 | Dec 2024 to 2027 |
| PSS | Oxycodone hydrochloride | Inj 10 mg per ml, 2 ml ampoule | Hameln | 2631180 | Dec 2024 to 2027 |
| PSS | Oxycodone hydrochloride | Inj 50 mg per ml, 1 ml ampoule | Hameln | 2631199 | Dec 2024 to 2027 |
| PSS | Oxycodone hydrochloride | Tab controlled-release 10 mg | Oxycodone Sandoz | 2559722 | Dec 2024 to 2027 |
| PSS | Oxycodone hydrochloride | Tab controlled-release 20 mg | Oxycodone Sandoz | 2559730 | Dec 2024 to 2027 |
| PSS | Oxycodone hydrochloride | Tab controlled-release 40 mg | Oxycodone Sandoz | 2559749 | Dec 2024 to 2027 |
| PSS | Oxycodone hydrochloride | Tab controlled-release 5 mg | Oxycodone Sandoz | 2559714 | Dec 2024 to 2027 |
| PSS | Oxycodone hydrochloride | Tab controlled-release 80 mg | Oxycodone Sandoz | 2559757 | Dec 2024 to 2027 |
| PSS | Oxytocin | Inj 10 iu per ml, 1 ml ampoule | Oxytocin BNM | 2577046 | Jun 2023 to 2025 |
| PSS | Oxytocin | Inj 5 iu per ml, 1 ml ampoule | Oxytocin BNM | 2448211 | Jun 2023 to 2025 |
| PSS | Oxytocin with ergometrine maleate | Inj 5 iu with ergometrine maleate 500 mcg per ml, 1 ml ampoule | Syntometrine | 256269 | Dec 2022 to 2025 |
| PSS | Paclitaxel | Inj 6 mg per ml, 16.7 ml vial | Anzatax | 2271834 | Aug 2024 to 2026 |
| PSS | Paclitaxel | Inj 6 mg per ml, 50 ml vial | Anzatax | 2271818 | Aug 2024 to 2026 |
| PSS | Pantoprazole | Tab EC 20 mg | Panzop Relief | 2637146 | Dec 2023 to 2025 |
| PSS | Pantoprazole | Tab EC 40 mg | Panzop Relief | 2637154 | Dec 2023 to 2025 |
| PSS | Paracetamol | Oral liq 120 mg per 5 ml | Paracetamol (Ethics) | 2650665 | Jun 2023 to 2025 |
| PSS | Paracetamol | Oral liq 250 mg per 5 ml | Pamol | 2643650 | Apr 2023 to 2025 |
| PSS | Paracetamol | Suppos 125 mg | Gacet | 2482711 | Feb 2024 to 2026 |
| PSS | Paracetamol | Suppos 250 mg | Gacet | 2482738 | Feb 2024 to 2026 |
| PSS | Paracetamol | Suppos 500 mg | Gacet | 2552663 | Feb 2024 to 2026 |
| HSS | Paracetamol | Tab 500 mg - blister pack - 1,000 tablet pack | Pacimol | 2612712 | Feb 2022 to 2026 |
| HSS | Paracetamol | Tab 500 mg - bottle pack | Noumed Paracetamol | 2611430 | Feb 2022 to 2026 |
| PSS | Paracetamol with codeine | Tab paracetamol 500 mg with codeine phosphate 8 mg | Paracetamol + Codeine (Relieve) | 2461234 | Jan 2023 to 2025 |
| PSS | Paraffin | Oint liquid paraffin 50% with white soft paraffin 50% | White Soft Liquid Paraffin AFT | 2639114 | May 2023 to 2025 |
| PSS | Paraffin | White soft, | EVARA White Soft Paraffin | 2664178 | Jun 2024 to 2026 |
| PSS | Parecoxib | Inj 40 mg vial | Dynastat | 2394804 | Dec 2024 to 2027 |
| PSS | Paroxetine | Tab 20 mg | Loxamine | 2626799 | Jan 2023 to 2025 |
| PSS | Pegfilgrastim | Inj 6 mg per 0.6 ml syringe | Ziextenzo | 2643340 | Jun 2023 to 2025 |
| PSS | Pemetrexed | Inj 100 mg vial | Pemetrexed-AFT | 2693917 | Apr 2025 to 2027 |
| PSS | Pemetrexed | Inj 500 mg vial | Pemetrexed-AFT | 2693925 | Apr 2025 to 2027 |
| PSS | Perindopril | Tab 2 mg | Coversyl | 2603942 | Dec 2024 to 2027 |
| PSS | Perindopril | Tab 4 mg | Coversyl | 2603950 | Dec 2024 to 2027 |
| PSS | Perindopril | Tab 8 mg | Coversyl | 2643316 | Dec 2024 to 2027 |
| PSS | Permethrin | Lotn 5% | A-Scabies | 2332027 | Feb 2024 to 2026 |
| PSS | Pethidine hydrochloride | Tab 50 mg | Noumed Pethidine | 2645599 | Aug 2023 to 2025 |
| PSS | Phenobarbitone | Tab 15 mg | Noumed Phenobarbitone | 2647524 | Aug 2024 to 2025 |
| PSS | Phenobarbitone | Tab 30 mg | Noumed Phenobarbitone | 2647532 | Dec 2023 to 2025 |
| PSS | Phenoxymethylpenicillin [Penicillin V] | Cap 250 mg | Cilicaine VK | 2602865 | Feb 2025 to 2027 |
| PSS | Phenoxymethylpenicillin [Penicillin V] | Cap 500 mg | Cilicaine VK | 2602873 | Feb 2025 to 2027 |
| PSS | Phenoxymethylpenicillin [Penicillin V] | Grans for oral liq 125 mg per 5 ml | AFT | 2029219 | Jan 2023 to 2025 |
| PSS | Phenoxymethylpenicillin [Penicillin V] | Grans for oral liq 250 mg per 5 ml | AFT | 2029227 | Jan 2023 to 2025 |
| PSS | Pimecrolimus | Crm 1% | Elidel | 2098873 | Feb 2024 to 2026 |
| PSS | Pine tar with trolamine laurilsulfate and fluorescein | Soln 2.3% with trolamine laurilsulfate and fluorescein sodium | Pinetarsol | 307661 | Feb 2024 to 2026 |
| PSS | Pioglitazone | Tab 15 mg | Vexazone | 2479435 | Dec 2024 to 2027 |
| PSS | Pioglitazone | Tab 30 mg | Vexazone | 2479443 | Dec 2024 to 2027 |
| PSS | Pioglitazone | Tab 45 mg | Vexazone | 2479451 | Dec 2024 to 2027 |
| PSS | Piperacillin with tazobactam | Inj 4 g with tazobactam 0.5 g vial | PipTaz-AFT | 2529866 | Feb 2023 to 2025 |
| PSS | Pneumococcal (PCV13) conjugate vaccine | Inj 30.8 mcg of pneumococcal polysaccharide serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F in 0.5 ml syringe | Prevenar 13 | 2383047 | Dec 2024 to 2027 |
| PSS | Pneumococcal (PCV13) conjugate vaccine | Inj 30.8 mcg of pneumococcal polysaccharide serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F in 0.5 ml syringe | Prevenar 13 | 2451085 | Dec 2024 to 2027 |
| PSS | Pneumococcal (PPV23) polysaccharide vaccine | Inj 575 mcg in 0.5 ml prefilled syringe (25 mcg of each 23 pneumococcal serotype) | Pneumovax 23 | 2478838 | Dec 2024 to 2027 |
| PSS | Poliomyelitis vaccine | Inj 80 D-antigen units in 0.5 ml syringe | IPOL | 216909 | Dec 2024 to 2027 |
| PSS | Poloxamer | Oral drops 10% | Coloxyl | 252816 | Feb 2024 to 2026 |
| PSS | Pomalidomide | Cap 1 mg | Pomolide | 2680297 | Aug 2024 to 31~Jul~2027 |
| PSS | Pomalidomide | Cap 1 mg | Pomolide | 2680300 | Aug 2024 to 31~Jul~2027 |
| PSS | Pomalidomide | Cap 2 mg | Pomolide | 2680319 | Aug 2024 to 31~Jul~2027 |
| PSS | Pomalidomide | Cap 2 mg | Pomolide | 2680327 | Aug 2024 to 31~Jul~2027 |
| PSS | Pomalidomide | Cap 3 mg | Pomolide | 2680335 | Aug 2024 to 31~Jul~2027 |
| PSS | Pomalidomide | Cap 3 mg | Pomolide | 2680343 | Aug 2024 to 31~Jul~2027 |
| PSS | Pomalidomide | Cap 4 mg | Pomolide | 2680351 | Aug 2024 to 31~Jul~2027 |
| PSS | Pomalidomide | Cap 4 mg | Pomolide | 2680378 | Aug 2024 to 31~Jul~2027 |
| PSS | Posaconazole | Oral liq 40 mg per ml | Devatis | 2645181 | May 2023 to 2025 |
| PSS | Posaconazole | Tab modified-release 100 mg | Posaconazole Juno | 2631008 | Apr 2023 to 2025 |
| PSS | Potassium iodate | Tab 253 mcg (150 mcg elemental iodine) | NeuroTabs | 2439964 | Feb 2024 to 2026 |
| PSS | Pramipexole hydrochloride | Tab 0.25 mg | Ramipex | 2450534 | Dec 2022 to 2025 |
| PSS | Pramipexole hydrochloride | Tab 1 mg | Ramipex | 2450542 | Dec 2022 to 2025 |
| PSS | Pravastatin | Tab 20 mg | Clinect | 2665204 | May 2024 to 2026 |
| PSS | Pravastatin | Tab 40 mg | Clinect | 2665212 | May 2024 to 2026 |
| PSS | Prednisolone | Oral liq 5 mg per ml | Redipred | 317659 | Dec 2024 to 2027 |
| PSS | Pregnancy test - hCG urine | Cassette | David One Step Cassette Pregnancy Test | 2602318 | Mar 2025 to 2027 |
| PSS | Prochlorperazine | Tab 5 mg | Nausafix | 2528886 | Mar 2024 to 2026 |
| PSS | Progesterone | Cap 100 mg | Utrogestan | 2086905 | May 2023 to 2025 |
| PSS | Promethazine hydrochloride | Tab 10 mg | Allersoothe | 2238098 | Sep 2022 to 2025 |
| PSS | Promethazine hydrochloride | Tab 25 mg | Allersoothe | 2238128 | Sep 2022 to 2025 |
| PSS | Propofol | Inj 10 mg per ml, 20 ml ampoule | Fresofol 1% MCT/LCT | 2444003 | Jan 2023 to 2025 |
| PSS | Propofol | Inj 10 mg per ml, 100 ml vial | Fresofol 1% MCT/LCT | 2444038 | Jan 2023 to 2025 |
| PSS | Propofol | Inj 10 mg per ml, 50 ml vial | Fresofol 1% MCT/LCT | 2444011 | Jan 2023 to 2025 |
| HSS | Propranolol | Tab 10 mg | Drofate | 2611414 | Mar 2022 to 2027 |
| HSS | Propranolol | Tab 40 mg | IPCA-Propranolol | 2618664 | Mar 2022 to 2027 |
| PSS | Pyridoxine hydrochloride | Tab 25 mg | Vitamin B6 25 | 2473534 | Feb 2024 to 2026 |
| PSS | Quetiapine | Tab 100 mg | Quetapel | 2252880 | Feb 2024 to 2026 |
| PSS | Quetiapine | Tab 200 mg | Quetapel | 2252902 | Feb 2024 to 2026 |
| PSS | Quetiapine | Tab 25 mg | Quetapel | 2476266 | Feb 2024 to 2026 |
| PSS | Quetiapine | Tab 300 mg | Quetapel | 2476274 | Feb 2024 to 2026 |
| PSS | Quinapril | Tab 10 mg | Arrow-Quinapril 10 | 2427885 | Mar 2025 to 2027 |
| PSS | Quinapril | Tab 20 mg | Arrow-Quinapril 20 | 2427893 | Mar 2025 to 2027 |
| PSS | Quinapril | Tab 5 mg | Arrow-Quinapril 5 | 2427877 | Mar 2025 to 2027 |
| PSS | Ramipril | Cap 1.25 mg | Tryzan | 2635747 | Feb 2025 to 2027 |
| PSS | Ramipril | Cap 10 mg | Tryzan | 2635771 | Feb 2025 to 2027 |
| PSS | Ramipril | Cap 2.5 mg | Tryzan | 2635755 | Feb 2025 to 2027 |
| PSS | Ramipril | Cap 5 mg | Tryzan | 2635763 | Feb 2025 to 2027 |
| PSS | Remifentanil | Inj 1 mg vial | Remifentanil-AFT | 2390388 | Feb 2024 to 2026 |
| PSS | Remifentanil | Inj 2 mg vial | Remifentanil-AFT | 2390396 | Feb 2024 to 2026 |
| PSS | Rifampicin | Cap 150 mg | Rifadin | 251186 | Dec 2023 to 2026 |
| PSS | Rifampicin | Cap 300 mg | Rifadin | 251194 | Dec 2023 to 2026 |
| PSS | Rifampicin | Inj 600 mg vial | Rifadin | 698121 | Dec 2023 to 2026 |
| PSS | Rifampicin | Oral liq 100 mg per 5 ml | Rifadin | 251208 | Dec 2023 to 2026 |
| PSS | Rifaximin | Tab 550 mg | Xifaxan | 2449935 | Dec 2024 to 2027 |
| PSS | Riluzole | Tab 50 mg | Rilutek | 238732 | Feb 2025 to 2027 |
| PSS | Risedronate sodium | Tab 35 mg | Risedronate Sandoz | 2440202 | Jun 2023 to 2025 |
| PSS | Risperidone | Oral liq 1 mg per ml | Risperon | 2325640 | Mar 2024 to 2026 |
| PSS | Risperidone | Tab 0.5 mg | Risperidone (Teva) | 2466899 | Mar 2024 to 2026 |
| PSS | Risperidone | Tab 1 mg | Risperidone (Teva) | 2466902 | Mar 2024 to 2026 |
| PSS | Risperidone | Tab 2 mg | Risperidone (Teva) | 2466910 | Mar 2024 to 2026 |
| PSS | Risperidone | Tab 3 mg | Risperidone (Teva) | 2466929 | Mar 2024 to 2026 |
| PSS | Risperidone | Tab 4 mg | Risperidone (Teva) | 2466937 | Mar 2024 to 2026 |
| PSS | Rivaroxaban | Tab 10 mg | Xarelto | 2545152 | Dec 2023 to 2026 |
| PSS | Rivaroxaban | Tab 15 mg | Xarelto | 2425920 | Dec 2023 to 2026 |
| PSS | Rivaroxaban | Tab 20 mg | Xarelto | 2425947 | Dec 2023 to 2026 |
| PSS | Rivastigmine | Patch 4.6 mg per 24 hour | Rivastigmine Patch BNM 5 | 2611570 | Mar 2025 to 2027 |
| PSS | Rivastigmine | Patch 9.5 mg per 24 hour | Rivastigmine Patch BNM 10 | 2611589 | Mar 2025 to 2027 |
| PSS | Rizatriptan | Tab orodispersible 10 mg | Rizamelt | 2394634 | Feb 2024 to 2026 |
| PSS | Rocuronium bromide | Inj 10 mg per ml, 5 ml ampoule | Hameln | 2577143 | Jan 2023 to 2025 |
| PSS | Ropinirole hydrochloride | Tab 0.25 mg | Ropin | 2310856 | Jan 2023 to 2025 |
| PSS | Ropinirole hydrochloride | Tab 1 mg | Ropin | 2310864 | Jan 2023 to 2025 |
| PSS | Ropinirole hydrochloride | Tab 2 mg | Ropin | 2310872 | Jan 2023 to 2025 |
| PSS | Ropinirole hydrochloride | Tab 5 mg | Ropin | 2310880 | Jan 2023 to 2025 |
| PSS | Ropivacaine hydrochloride | Inj 10 mg per ml, 10 ml ampoule | Ropivacaine Kabi | 2478749 | Feb 2024 to 2026 |
| PSS | Ropivacaine hydrochloride | Inj 10 mg per ml, 20 ml ampoule | Ropivacaine Kabi | 2478765 | Feb 2024 to 2026 |
| PSS | Ropivacaine hydrochloride | Inj 2 mg per ml, 10 ml ampoule | Ropivacaine Kabi | 2478757 | Feb 2024 to 2026 |
| PSS | Ropivacaine hydrochloride | Inj 2 mg per ml, 20 ml ampoule | Ropivacaine Kabi | 2478714 | Feb 2024 to 2026 |
| PSS | Ropivacaine hydrochloride | Inj 2 mg per ml, 100 ml bag | Ropivacaine Kabi | 2479125 | Feb 2024 to 2026 |
| PSS | Ropivacaine hydrochloride | Inj 2 mg per ml, 200 ml bag | Ropivacaine Kabi | 2479117 | Feb 2024 to 2026 |
| PSS | Ropivacaine hydrochloride | Inj 7.5 mg per ml, 10 ml ampoule | Ropivacaine Kabi | 2478722 | Feb 2024 to 2026 |
| PSS | Ropivacaine hydrochloride | Inj 7.5 mg per ml, 20 ml ampoule | Ropivacaine Kabi | 2478730 | Feb 2024 to 2026 |
| PSS | Rosuvastatin | Tab 10 mg | Rosuvastatin Viatris | 2651149 | Oct 2024 to 2026 |
| PSS | Rosuvastatin | Tab 20 mg | Rosuvastatin Viatris | 2651157 | Apr 2024 to 2026 |
| PSS | Rosuvastatin | Tab 40 mg | Rosuvastatin Viatris | 2651165 | Apr 2024 to 2026 |
| PSS | Rosuvastatin | Tab 5 mg | Rosuvastatin Viatris | 2651130 | Oct 2024 to 2026 |
| PSS | Rotavirus oral vaccine | Oral susp live attenuated human rotavirus 1,000,000 CCID50 per dose, prefilled oral applicator | Rotarix | 2509415 | Dec 2024 to 2027 |
| PSS | Roxithromycin | Tab 150 mg | Arrow-Roxithromycin | 2246236 | Aug 2023 to 2026 |
| PSS | Roxithromycin | Tab 300 mg | Arrow-Roxithromycin | 2246228 | Aug 2023 to 2026 |
| PSS | Sertraline | Tab 100 mg | Setrona | 2570858 | Apr 2023 to 2025 |
| PSS | Sertraline | Tab 50 mg | Setrona | 2570831 | Apr 2023 to 2025 |
| PSS | Sildenafil | Tab 100 mg | Vedafil | 2377810 | Dec 2024 to 2027 |
| PSS | Sildenafil | Tab 25 mg | Vedafil | 2377764 | Dec 2024 to 2027 |
| PSS | Sildenafil | Tab 50 mg | Vedafil | 2377780 | Dec 2024 to 2027 |
| PSS | Simvastatin | Tab 10 mg | Simvastatin Mylan | 2520087 | Mar 2024 to 2026 |
| PSS | Simvastatin | Tab 20 mg | Simvastatin Viatris | 2643561 | Mar 2024 to 2026 |
| PSS | Simvastatin | Tab 40 mg | Simvastatin Viatris | 2643588 | Jun 2024 to 2026 |
| PSS | Simvastatin | Tab 80 mg | Simvastatin Viatris | 2643596 | Jun 2024 to 2026 |
| PSS | Sodium chloride | Inj 0.9%, 5 ml ampoule | Fresenius Kabi | 2565749 | Jan 2023 to 2025 |
| PSS | Sodium chloride | Inj 0.9%, 10 ml ampoule | Fresenius Kabi | 2565757 | Jan 2023 to 2025 |
| PSS | Sodium chloride | Inj 0.9%, 3 ml syringe, non-sterile pack | BD PosiFlush | 2476371 | Mar 2023 to 2025 |
| PSS | Sodium chloride | Inj 0.9%, 5 ml syringe, non-sterile pack | BD PosiFlush | 2476398 | Mar 2023 to 2025 |
| PSS | Sodium chloride | Inj 0.9%, 10 ml syringe, non-sterile pack | BD PosiFlush | 2476401 | Mar 2023 to 2025 |
| PSS | Sodium chloride | Inj 0.9%, 20 ml ampoule | Fresenius Kabi | 2565730 | Jan 2023 to 2025 |
| PSS | Sodium citrate with sodium lauryl sulphoacetate | Enema 90 mg with sodium lauryl sulphoacetate 9 mg per ml, 5 ml | Micolette | 2262673 | Jun 2023 to 2025 |
| PSS | Sodium citro-tartrate | Grans eff 4 g sachets | Ural | 298638 | Feb 2024 to 2026 |
| PSS | Sodium cromoglicate | Eye drops 2% | Allerfix | 2645416 | Mar 2023 to 2025 |
| PSS | Sodium fusidate [Fusidic acid] | Crm 2% | Foban | 2556170 | Feb 2025 to 2027 |
| PSS | Sodium fusidate [Fusidic acid] | Oint 2% | Foban | 2556189 | Feb 2025 to 2027 |
| PSS | Sodium hyaluronate [Hyaluronic acid] | Inj 18 mg per ml, 0.85 ml syringe | Healon GV Pro | 2618540 | Dec 2022 to 2025 |
| PSS | Sodium hyaluronate [Hyaluronic acid] | Inj 23 mg per ml, 0.6 ml syringe | Healon 5 | 346721 | Dec 2022 to 2025 |
| PSS | Sodium hyaluronate [Hyaluronic acid] | Eye drops 1 mg per ml | Hylo-Fresh | 2608162 | Dec 2024 to 2027 |
| PSS | Sodium hyaluronate [Hyaluronic acid] | Inj 10 mg per ml, 0.85 ml syringe | Healon | 470619 | Dec 2022 to 2025 |
| PSS | Somatropin | Inj 10 mg cartridge | Omnitrope | 2461528 | Feb 2025 to 2027 |
| PSS | Somatropin | Inj 15 mg cartridge | Omnitrope | 2461501 | Feb 2025 to 2027 |
| PSS | Somatropin | Inj 5 mg cartridge | Omnitrope | 2461536 | Feb 2025 to 2027 |
| PSS | Sotalol | Tab 160 mg | Mylan | 2127911 | Jan 2023 to 2025 |
| PSS | Sotalol | Tab 80 mg | Mylan | 2127903 | Jan 2023 to 2025 |
| PSS | Spironolactone | Tab 100 mg | Spiractin | 2435187 | Sep 2022 to 2025 |
| PSS | Spironolactone | Tab 25 mg | Spiractin | 2435179 | Sep 2022 to 2025 |
| PSS | Sugammadex | Inj 100 mg per ml, 2 ml vial | Sugammadex BNM | 2632314 | Dec 2024 to 2027 |
| PSS | Sugammadex | Inj 100 mg per ml, 5 ml vial | Sugammadex BNM | 2632322 | Dec 2024 to 2027 |
| PSS | Sumatriptan | Inj 12 mg per ml, 0.5 ml prefilled pen | Clustran | 2647958 | Apr 2024 to 2025 |
| HSS | Sumatriptan | Tab 100 mg | Sumagran | 2605856 | Feb 2022 to 2027 |
| HSS | Sumatriptan | Tab 50 mg | Sumagran | 2605848 | Feb 2022 to 2027 |
| PSS | Sunscreen, proprietary | Lotn | Marine Blue Lotion SPF 50+ | 2454203 | Apr 2023 to 2025 |
| PSS | Suxamethonium chloride | Inj 50 mg per ml, 2 ml ampoule | Martindale | 2442205 | Feb 2024 to 2026 |
| PSS | Tacrolimus | Oint 0.1% | Zematop | 2607646 | Dec 2023 to 2026 |
| PSS | Tamoxifen citrate | Tab 10 mg | Tamoxifen Sandoz | 2556944 | Dec 2023 to 2026 |
| PSS | Tamoxifen citrate | Tab 20 mg | Tamoxifen Sandoz | 2556952 | Dec 2023 to 2026 |
| PSS | Tamsulosin hydrochloride | Cap 400 mcg | Tamsulosin-Rex | 2438526 | Jan 2023 to 2025 |
| PSS | Teicoplanin | Inj 400 mg vial | Teicoplanin Medsurge | 2664372 | Apr 2025 to 2027 |
| PSS | Temazepam | Tab 10 mg | Normison | 2184877 | Feb 2024 to 2026 |
| PSS | Tenofovir disoproxil | Tab 245 mg (300 mg as a maleate) | Tenofovir Disoproxil Viatris | 2638061 | Sep 2023 to 2025 |
| PSS | Tenoxicam | Tab 20 mg | Tilcotil | 2520559 | Jan 2023 to 2025 |
| PSS | Terbinafine | Tab 250 mg | Deolate | 2597160 | Feb 2024 to 2026 |
| PSS | Teriflunomide | Tab 14 mg | Teriflunomide Sandoz | 2691426 | Apr 2025 to 2026 |
| PSS | Teriparatide | Inj 250 mcg per ml, 2.4 ml | Teriparatide - Teva | 2670399 | Jun 2024 to 2025 |
| PSS | Terlipressin | Inj 1 mg per 8.5 ml ampoule | Terlipressin Ever Pharma | 2689359 | Feb 2025 to 2027 |
| PSS | Testosterone | Gel (transdermal) 16.2 mg per g | Testogel | 2676605 | Jul 2024 to 2027 |
| PSS | Tetrabenazine | Tab 25 mg | Motetis | 2394383 | Apr 2023 to 2025 |
| PSS | Thiamine hydrochloride | Tab 50 mg | Thiamine multichem | 2646552 | Apr 2023 to 2025 |
| PSS | Thiotepa | Inj 100 mg vial | Tepadina | 2487977 | Apr 2024 to 2026 |
| PSS | Thiotepa | Inj 15 mg vial | Tepadina | 2487985 | Apr 2024 to 2026 |
| PSS | Ticagrelor | Tab 90 mg | Ticagrelor Sandoz | 2638770 | Dec 2024 to 2027 |
| PSS | Timolol | Eye drops 0.25% | Arrow-Timolol | 2390663 | Mar 2024 to 2026 |
| PSS | Timolol | Eye drops 0.5% | Arrow-Timolol | 2390655 | Mar 2024 to 2026 |
| PSS | Tobramycin | Solution for inhalation 60 mg per ml, 5 ml | Tobramycin BNM | 2601648 | Dec 2023 to 2026 |
| PSS | Tobramycin | Inj 40 mg per ml, 2 ml vial | Tobramycin (Viatris) | 2635690 | Dec 2024 to 2027 |
| PSS | Tramadol hydrochloride | Cap 50 mg | Arrow-Tramadol | 2351889 | Jan 2024 to 2026 |
| PSS | Tramadol hydrochloride | Inj 50 mg per ml, 2 ml ampoule | Tramal 100 | 471216 | May 2024 to 2026 |
| PSS | Tramadol hydrochloride | Inj 50 mg per ml, 2 ml ampoule | Tramal 100 | 2650932 | May 2024 to 2026 |
| PSS | Tramadol hydrochloride | Inj 50 mg per ml, 1 ml ampoule | Tramal 50 | 471208 | May 2024 to 2026 |
| PSS | Tramadol hydrochloride | Inj 50 mg per ml, 1 ml ampoule | Tramal 50 | 2650940 | May 2024 to 2026 |
| PSS | Tramadol hydrochloride | Tab sustained-release 100 mg | Tramal SR 100 | 2149508 | May 2024 to 2026 |
| PSS | Tramadol hydrochloride | Tab sustained-release 100 mg | Tramal SR 100 | 2650959 | May 2024 to 2026 |
| PSS | Tramadol hydrochloride | Tab sustained-release 150 mg | Tramal SR 150 | 2149532 | May 2024 to 2026 |
| PSS | Tramadol hydrochloride | Tab sustained-release 150 mg | Tramal SR 150 | 2650967 | May 2024 to 2026 |
| PSS | Tramadol hydrochloride | Tab sustained-release 200 mg | Tramal SR 200 | 2149524 | May 2024 to 2026 |
| PSS | Tramadol hydrochloride | Tab sustained-release 200 mg | Tramal SR 200 | 2650975 | May 2024 to 2026 |
| PSS | Tranexamic acid | Inj 100 mg per ml, 10 ml ampoule | Tranexamic-AFT | 2497174 | Mar 2025 to 2027 |
| PSS | Tranexamic acid | Inj 100 mg per ml, 5 ml ampoule | Tranexamic-AFT | 2497166 | Mar 2025 to 2027 |
| PSS | Tranexamic acid | Tab 500 mg | Mercury Pharma | 2574020 | Jun 2023 to 2025 |
| PSS | Trastuzumab (Herzuma) | Inj 150 mg vial | Herzuma | 2670127 | Jun 2024 to 31~May~2027 |
| PSS | Trastuzumab (Herzuma) | Inj 440 mg vial | Herzuma | 2670135 | Jun 2024 to 31~May~2027 |
| PSS | Travoprost | Eye drops 0.004% | Travatan | 2550091 | Dec 2024 to 2027 |
| PSS | Tretinoin | Crm 0.05% | ReTrieve | 2358751 | Feb 2025 to 2027 |
| PSS | Triamcinolone acetonide | Paste 0.1% | Kenalog in Orabase | 253790 | Feb 2024 to 2026 |
| PSS | Triamcinolone acetonide | Crm 0.02% | Aristocort | 250066 | Feb 2024 to 2026 |
| PSS | Triamcinolone acetonide | Oint 0.02% | Aristocort | 250082 | Feb 2024 to 2026 |
| PSS | Triamcinolone acetonide | Inj 10 mg per ml, 1 ml ampoule | Kenacort-A 10 | 282499 | Feb 2024 to 2026 |
| PSS | Triamcinolone acetonide | Inj 40 mg per ml, 1 ml ampoule | Kenacort-A 40 | 253766 | Feb 2024 to 2026 |
| PSS | Trientine | Cap 250 mg | Trientine Waymade | 2621738 | Oct 2024 to 2025 |
| PSS | Trimethoprim | Tab 300 mg | TMP | 648507 | Feb 2025 to 2027 |
| PSS | Trimethoprim with sulphamethoxazole [Co-trimoxazole] | Tab 80 mg with sulphamethoxazole 400 mg | Trisul | 283363 | Feb 2025 to 2027 |
| PSS | Tuberculin PPD [Mantoux] test | Inj 5 TU per 0.1 ml, 1 ml vial | Tubersol | 703338 | Dec 2024 to 2027 |
| PSS | Ursodeoxycholic acid | Cap 250 mg | Ursosan | 2397528 | Feb 2024 to 2026 |
| PSS | Valaciclovir | Tab 1,000 mg | Vaclovir | 2483912 | Feb 2025 to 2027 |
| PSS | Valaciclovir | Tab 500 mg | Vaclovir | 2483904 | Feb 2025 to 2027 |
| PSS | Valganciclovir | Tab 450 mg | Valganciclovir Viatris | 2635682 | Feb 2025 to 2027 |
| PSS | Vancomycin | Inj 500 mg vial | Mylan | 2195267 | Feb 2024 to 2026 |
| PSS | Varicella vaccine [Chickenpox vaccine] | Inj 2000 PFU prefilled syringe plus vial | Varilrix | 2678950 | Dec 2024 to 2027 |
| PSS | Vecuronium bromide | Inj 10 mg vial | Vecure | 2503379 | Apr 2025 to 2027 |
| PSS | Vinorelbine | Cap 20 mg | Vinorelbine Te Arai | 2651912 | Oct 2023 to 2025 |
| PSS | Vinorelbine | Cap 30 mg | Vinorelbine Te Arai | 2547880 | Oct 2023 to 2025 |
| PSS | Vinorelbine | Cap 80 mg | Vinorelbine Te Arai | 2651920 | Oct 2023 to 2025 |
| PSS | Voriconazole | Inj 200 mg vial | AFT | 2645122 | Aug 2023 to 2025 |
| PSS | Water | Inj 10 ml ampoule | Multichem | 2208326 | Sep 2023 to 2025 |
| PSS | Water | Inj 20 ml ampoule | Fresenius Kabi | 2565692 | Jan 2023 to 2025 |
| PSS | Zinc and castor oil | Oint | Evara | 2658399 | Nov 2023 to 2025 |
| PSS | Zoledronic acid | Inj 4 mg per 5 ml, vial | Zoledronic acid Viatris | 2631830 | Dec 2024 to 2027 |
| PSS | Zoledronic acid | Inj 5 mg per 100 ml, bag | Zoledronic Acid Viatris | 2636743 | Jun 2023 to 2025 |
| PSS | Zopiclone | Tab 7.5 mg | Zopiclone Actavis | 2480662 | Feb 2025 to 2027 |